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CHAPTER - I 
INTRODUCTION 
 
Traditional medicine is the sum total of the knowledge, skills and practices based on 
the theories, beliefs, and experiences indigenous to different cultures, whether explicable or 
nor used in the maintenance of health as well as in the prevention, diagnosis, or treatment of 
physical and mental illness. 
Traditional medicine that has been adopted by other populations (outside its 
indigenous culture) is often termed alternative or complementary medicine. 
  Herbal medicines include herbs, herbal materials, herbal preparations and finished 
herbal products that contain parts of plants or other plant materials as active ingredients (1). 
In the early stages, the science of medicine developed around those plants which had 
curative properties. A continued search for medicinal plants during the last several centuries 
has given rise to a long list of plants which are of great use in the treatment of diseases and 
for promoting health. It can be stated, more or less truthfully, that every disease has a cure 
with a plant growing in nature. 
The main limitation is the lack of standardization of raw materials, of processing 
methods and of the final products, dosage formulation and the non- existence of criteria for 
quality control. Research has to be directed to the use of modern scientific methodology and 
techniques to standardize all these different steps and quality control (2). 
Herbal medicine 
The world health organization(WHO) has recently defined traditional medicine 
(including herbal drugs) as comprising therapeutic practices that have been in existence, often 
for hundreds  of years, before the development and spread of modern medicine and are still in 
                                                                                                Introduction 
  
Department of Pharmacognosy, MMC Page 2 
 
use today. The traditional medicine is the synthesis of therapeutic experience of generations 
of practising physicians of indigenous system of medicine (3). 
The role of herbal medicines in traditional healing 
The pharmacological treatment of diseases began long ago with the use of herbs. 
Methods of folk healing throughout the world commonly use herbs as part of their tradition. 
Some of these traditions are providing some examples of the array of important healing 
practices around the world that use herbs for this purpose (4). 
Natural products for modern medicine 
Plants are being used in medicine from time immemorial because they have fitted the 
immediate personal need, they are accessible and inexpensive, the practitioners speak to those 
who have used them in their own language and they are not provided from a remote 
professional or Government apparatus. For these and other reasons, the use of plants for 
medicines around the world still vastly exceeds the use of modern synthetic drugs. Such 
activity is not completely dismissed in scientific society and plants are also appreciated in 
pharmaceutical research as the major resource for new medicines and a growing body of 
medical literature supports the clinical efficacy of herbal treatments. Even where traditional 
use has largely died out in developed countries, there is an increasing yearning for a new deal 
in healthcare in which the old remedies feature strongly. 
Researchers have no doubt that nature is still the preeminent synthetic chemist and 
that in plants particularly, there are almost infinite reserves of fascinating chemical 
constituents with actual and potential effects on the human body. As such information 
accumulates, it becomes possible to better understand traditional uses of plants. 
Natural products will continue to be important in three areas of drug discovery 
 As targets for production by biotechnology  
 As a source of new lead compounds of novel chemical structure and  
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 As the active ingredients of useful treatments derived from traditional systems of 
medicine. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Safaty in herbal drugs 
Major differences in the assessment of quality, safety and efficacy would hinder free 
circulation of herbal medicinal products may represent a risk for consumers. The complexity 
of herbal drug preparations and the interpretation of bibliographic data on safety and efficacy 
reflecting the experience gathered during long- term use are best addressed by involving 
specific expertise and experience. Safety and efficacy of complex biological products, such as 
herbal medicinal products are directly linked to pharmaceutical details such as the way of 
production and the specification of extracts. 
Names of plants given in 
ancient textbooks of 
Chinese, Indian and other 
system of medicine 
SELECTION OF 
PLANT MATERIALS 
FOR RESEARCH
Natural selection of 
medicinal plants which are 
mentioned in ancient texts 
and are still in use today
Names of plants given in 
early writings of 
explorers, missionaries, 
writers & herbalists 
Plants that are actually 
being used today even 
though no mention has 
been recorded earlier 
Published papers and 
unpublished work of 
research carried out 
with plants- 
experimental or clinical 
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A consistent quality of herbal drugs may need more detailed information on aspects of 
agricultural production. The selection of seeds, conditions of cultivation and harvesting 
represent an important aspect in producing a reproducible quality of herbal drugs. Ongoing 
discussions on Good Agricultural Practices (GAP) for medicinal plants should be monitored 
regularly (5). 
Significances of medicinal plants to human being 
 Many of the modern medicines are produced indirectly from medicinal plants for 
example Aspirin 
 Plants are directly used as medicines by a majority of cultures around the world. For 
example, Chinese medicine and Indian medicine 
 Many food crops have medicinal effects. For example, Garlic 
 Medicinal plants are resources of new drugs. It is estimated that there are more than 
250,000 flower plant species. 
 Studying medicinal plant helps us to understand plant toxicity and protect human and 
animals from natural poisons. 
 Cultivation and preservation of medicinal plants protect biological diversity. For 
example metabolic engineering of plants (6) 
 Inflammation 
Inflammation is part of the complex biological response of vascular tissues to harmful 
stimuli, such as pathogens damaged cells, or irritants (7).    The classical signs of acute 
inflammation are pain, heat, redness, swelling and loss of function.   Inflammation is a 
protective attempt by the organism to remove the injurious stimuli and to initiate the healing 
process. 
Inflammation is not a synonym for infection, even in cases where inflammation is 
caused by infection. Although infection is caused by a microorganism,inflammation is one of 
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Classification  
 Acute inflammation 
 Chronic inflammation 
Acute inflammation is the initial response of the body to harmful stimuli and is achieved by 
the increased movement of plasma and leukocytes (especially granulocytes) from the blood 
into the injured tissues. A cascade of biochemical events propagates and matures the 
inflammatory response, involving the local vascular system, the immune system and various 
cells within the injured tissue. 
Prolonged inflammation known as chronic inflammation leads to a progressive shift 
in the type of cells present at the site of inflammation and is characterized by simultaneous 
destruction and healing of the tissue from the inflammatory process. 
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Table:1: Comparison between acute and chronic inflammation 
 
CAUSES 
ACUTE 
INFLAMMATION 
CHRONIC 
INFLAMMATION 
Causative agent 
 
Bacterial pathogens, injured 
tissues 
Persistent acute inflammation 
due to non- degradable 
pathogens, viral infection, 
persistent foreign bodies or 
acute immune reactions. 
Major cells involved 
 
Neutrophils(primary) 
basophils ( in inflammatory 
response) and eosinophila 
(response to helminth worms 
and parasites) monocellular 
cells (monocytes,  
macrophages) 
Monocellular 
cells(Monocytes, 
macrophages, lymphocytes, 
plasma cells) fibroblasts 
 
Primary mediators 
 
Vasoactive amines, 
eicosanoids  
IFN –Y and other cytokines, 
growth factor, reactive oxygen 
species, hydrolytic enzymes 
Onset Immediate Delayed 
Duration Few days  Upto many months or years 
Outcomes  Resolution, abscess formation, 
chronic inflammation 
Tissue destruction, fibrosis, 
necrosis 
 
The five cardial signs of acute inflammation “PRISH”  
PAIN – The inflamed area is likely to be painful, especially when touched. Chemicals that 
stimulate nerve endings are released, making the area much more sensitive. 
REDNESS – This is because ofthe capillaries are filled up with more blood than usual. 
IMMOBILITY – There may be some loss of function 
SWELLING – Caused by an accumulation of fluid. 
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Anti – inflammatory herbs and species 
 Black pepper 
 Basil 
 Cardamom 
 Chamomile 
 Chives 
 Cinnamon 
 Cloves 
 Garlic 
 Ginger 
 Parsley 
 Nutmeg 
 Rosemary 
 Turmeric (11) 
 
The extracts of Achillea millefolium, Artemisia vulgaris, Bauhinia tarapotensis, 
Curcuma longa, Forsythia suspense, Houttuynia cordata, Glycyrrhiza uralensis, Lonicera 
japonica and ValerianaWallichi have show anti- inflammatory activity (12). 
Antibacterial activity 
An antimicrobial is an agent that kills microorganisms or inhibits their growth. 
Antimicrobial medicines can be grouped according to the microorganisms they act primarily 
against.  For example, antibacterial (commonly known as antibiotics) are used against 
bacteria and antifungal are used against fungi. Antimicrobials that kill microbes are called 
microbicidal. Those that merely inhibit their growth are called microbiostatic.  Disinfectants 
such as bleach are non- selective antimicrobials (13). 
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An infection and immunity involve interaction between the animal body (host) and 
the infecting microorganism. Based on their relationships to their hosts, microorganism can 
be classified as saprophytes (from Greek sapros decayed; and phyton plant) and parasites. 
Saprophytes are free - living microbes that subsist on dead or decaying organic 
matter. They are found in soil and water and play an important role in the degradation of 
organic materials in nature. 
Parasites are microbes that can establish themselves and multiply in hosts. Parasitic 
microbes may be either pathogens (from Greek, pathos- suffering and gen- produce i.e 
disease- producing) or commensals (from Latin, com – with  and mensa-living together). 
Pathogens are microorganisms that are capable of producing disease in the host. 
Commensal microbes live in complete harmony with the host without causing any damage to 
it. The normal bacterial flora of the body consists largely of commensals. Many commensals 
behave as facultative pathogens in that they can produce disease when the host resistance is 
lowered. 
Infections may be classified in various ways 
 Initial infection with a parasite in a host is termed primary infection 
 Subsequent infections by the same parasite in the host are termed reinfections. 
 When a new parasite sets up an infection in a host whose resistance is lowered by a 
preexisting infectious disease, this is termed secondary infection 
 Focal infection (more appropriately focal sepsis) indicates a condition where, due to 
infection or sepsis at localized sites such as the appendix or tonsils generalized effects 
are produced. 
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 When in a patient already suffering from a disease, a new infection is set up from 
another host or another external source it is termed cross-infection. 
 In-apparent infection is one where the clinical effects are not apparent. The term 
subclinical infection is often used as a synonym. 
 Atypical infection is one in which the typical or characteristic clinical manifestation of 
the particular infectious disease are not present (14). 
Infections may be divided into following 
 Bacterial infections  
 Fungal infections 
 Parasitic infections 
 Protozoan infections 
 Viral infections 
 Worm infections 
Bactrial infections 
Pathogenic bacteria are bacteria which causes bacterial infections. Although the vast 
majority of bacteria are harmless or beneficial, quite a few bacteria are pathogenic. The 
highly pathogenic bacteria are classified in to two types “gram positive bacteria” and “gram 
negative bacteria”. The pathogenic bacteria contribute to globally important diseases such as 
pneumonia, which are caused by bacteria such as streptococcus and pseudomonas and food 
borne illness such as tetanus, typhoid fever, diphtheria, syphilis, and leprosy (15). 
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Gram positive bacteria Gram negative bacteria 
Staphylococcus aureus 
Basillus subtilis 
Streptococcus viridians,  
S. pyogens 
Esherichia coli 
Klebsiella 
Pseudomonas aeruginosa 
Salmonella typhi 
Proteus albus 
 
Major characteristics of microorganisms fall into the following categories 
 Morphological characteristics cell shape, size and structure; cell arrangement; 
occurrence of special structures and developmental forms; staining reaction and 
motility and flagellar arrangement. 
 Chemical composition  - The various chemical constituents of the cells 
 Cultural characteristics   - Nutritional requirements and physical conditions required 
for growth and the manner in which growth occur. 
 Metabolic characteristics-The way in which cells obtain and use their energy to 
carry out chemical reactions and regulate those reactions 
 Antigenic characteristics -   Special range chemical components (antigens) of the 
cell, distinctive for certain kinds of microorganisms. 
 Genetic characteristics - characteristic of the hereditary material of the cell (DNA) 
and occurrence and function of other kinds of DNA that may be present, such as 
plasmids. 
 Pathogenecity- The ability to cause disease in various plants or animals or even other 
microorganisms. 
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 Ecological characteristics - Habitat and the distribution of the organisms in the 
nature and the interactions between and among species in natural environments (16). 
Mechanism of action of antimicrobial drugs 
Antimicrobial agent may act by destroying the organism (bactericidal) or by 
inhibiting its growth (bacteriostatic). Bactericidal drugs in general are most effective against 
rapidly multiplying bacteria, often a bacteriostatic drug in higher concentration may act as 
bactericidal. 
The selective toxic action on the infecting organism is the key to beneficial actions of 
antibiotics.These drugs can hit multiple targets in bacterial cell. 
 The cell wall 
 The cytoplasmic membrane  
 The ribosomes 
 The RNA molecules involved in transcription of genetic formation 
 Enzymes required for DNA synthesis replication 
 Metabolic pathways. 
Antimicrobial agents 
Antimicrobial drugs are effective in the treatment of infections because of their 
selective toxicity (i.e they have ability to kill or inhibit the growth of an invading 
microorganism without harming the cells of the host). In most instances, the selective toxicity 
is relative, rather than absolute, requiring that the concentration of the drug be carefully 
controlled to attack the microorganism while still being tolerated by the host. Selective 
antimicrobial therapy takes advantage of the biochemical differences that exist between 
microorganisms and human beings. 
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Agents used to treat bacterial infections 
 Penicillin 
 Cephalosporin 
 Tetracyclines 
 Aminoglycosides 
 Macrolides 
 Fluoroquinolones  (17). 
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CHAPTER-II 
LITERATURE REVIEW 
The literature review of Cordia obliqua willd. and its related species reveals that the 
following works have been done on the plant. But the proper scientific studies have not been 
reported for the plant Cordia obliqua. As there is no pharmacognostic, phytochemical  and 
pharmacological work of this traditionally much valued drug, the present work was taken up 
with a view to lay down the standards, which could be useful to detect the authenticity of this 
underutilized medicinally useful plant. 
CORDIA OBLIQUA  
VK. Agnihorti et al., (1987) have reported the chemical composition of the seeds of 
Cordia obliqua and isolated and characterized the presence of alpha- amyrin, betulin, 
octacosanol,lupeol- 3- rhamnoside, bêta – sitosterol, beta – sitosterolul- 3- glucoside, 
hentricontanol, hentricontane, taxifolin- 3, 5 –di rhamnoside and hesperetin- 7- rhamnose. 
The anti- inflammatory activity of the isolated compounds were determined.(18). 
N.K. Udayaprakash., (2013) have studied the presence of phytochemicals in the 
aqueous extract of 100 different plants species including Cordia belonging to 44 families 
collected from Chennai, India.(19) 
R.R.A. Abou- Shaaban et al., (2007) have reported the comparative pharmacological 
activity of cordia fruit mucilage at different stages of maturity, to determine the stage at 
which active substances were present in high propotions. Mucilage from both ripe and unripe 
Cordia obliqua decreased rabbit blood pressure and stimulates the respiratory rate.(20) 
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K. Thirupathi et al., (2008) have studied the pharmacological activities with extracts 
and purified compound indicates that the plants of cordia species possess analgesic, anti- 
inflammatory, anti microbial, anti viral, anti- fertility activities.(21) 
Cordia malleodii 
S.K. Sen et al., (2005) have reported that the leaves of Cordia malleodii plant, when 
crushed and applied on a fresh cut injury, bleeding stops forth with and the injury heals up 
quickly.(22) 
Cordia sebestena 
S. Jeera et al., (2011) have studied the phytochemical constituents and anti-bacterial 
activity of the flower extracts of Cordia sebestena.(23)  
J. Dai et al., (2010) have studied the bio assay guided fractionation of an extract 
prepared from the fruits of Cordia sebestena led to the isolation of sebestenoids A-D           
(1-4).The fruits of Cordia sebestena yielded four  phenyl propanoid esters, sebestenoids A-D 
(1-4). (24) 
Cordia piauhensis 
G.M.P. Santiago et al., (2005) have reported the larvicidal activity of the four 
monodesmoside saponins isolated from Penaclethra macroloba (Boraginaceae) and one 
bidesmoside saponin from Cordia piauhensis on 3rd instar larvae of Aedes aegypti.(25) 
Cordia alliodora 
A.K. Sinha  et al., (2003) have synthesized methyl 2, 4, 5-trimethyl phenyl 
propionate by esterification of phenyl propionic acid with methanol, a metabolite of Cordia 
alliodora (94 percent yield within 3 minutes) by microwave assisted technique.(26) 
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Kloucek et al., (2007) have reported  that the ethanol extract of stem bark of Cordia 
alliodora was effective against nine bacteria & one yeast using the broth micro dilution 
method. (27) 
J.R. Loset  et al ., ( 2000) have reported that the root bark of Cordia alliodora have 
anti fungal properties against the pathogenic mold elodesporium cucumerinum and a marked 
activity against larvae of the yellow fever transmitting mosquito Aedes aegypti.(28)  
S. Kaur et al., (2010) have isolated 1,3-methoxy propanoyl-2, 4, 5-trimethoxy 
benzene  from Cordia alliodora. Methoxy propanoyl trimethoxy benzene was reported to 
have antifungal and larvicidal activities against the phytopathogenic mould cladasporium 
cucumerinum and the larvae of yellow fever transmitting mosquito, Aedes aegypti 
respectively.(29). 
Cordia verbenaceae 
JS. Chaves et al., (2008) have reported a quantitative study  to assess the plasma and 
tissue levels, tissue distribution and skin (ear) absorption of the sesquiterpene, alpha- 
humulene, the main active constituent isolated from the plant Cordia verbenaceae 
(Boraginaceae), after oral, intravenous and topical administration in mice. The alpha-
humulene levels in tissues were quantified by GC-MS analysis. Its high amount was found in 
the liver followed by the kidneys, heart, lungs, spleen and brain, 0.5 hour after oral 
administration.(30) 
F. RoldaoEde et al., (2008) have reported the antiulcer activity of Cordia 
verbenaceae extract which was evaluated using ethanol & piroxicam-induced gastric lesions 
method. Analgesic activity was evaluated by writhing, tail-flick & hot plate method. 
Antioxidant activity was determined by in vitro lipoper-oxidation assay.(31) 
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DM. De Oliveira et al., (2011) have reported that the Cordia verbenaceae inhibit the 
in-vitro secretion of histamine from mast cells of different animal species as well as the 
secretion of mast cells from animals treated with the extract.(32) 
A.A.M. Oliveira et al., (1998) have reported the oral administration of the hydro 
alcoholic extracts of Cordia verbenaceae leaves in rats after 30 days caused no changes of 
serum parameters, cardiac function & toxic effect.(33) 
Cordia dichotoma 
D.N. Khairnar., (2006) have reported the medico-ethnological data regarding the 
specific parts of the different medicinal plants together with the ailments that can be treated  
and the specific uses of this plants in preventive, promotion and curative applications 
obtained from the tribal’s well acquainted with medicinal plants Cordia dichotoma 
(Boraginaceae).(34) 
Sumitra Singh et al., (2008) have reported the analgesic activity of different extracts 
ofCordia dichotoma (Boraginaceae) studied  in Swiss albino mice.(35) 
I.J. Kuppasta et al., (2003) have studied the in vitro anthelmintic activity of the 
butanol fractionated extract of the Cordia dichotoma against earth worms, tape worms and 
round worms.(36) 
B.A.Jadeja et al.,(2008) have reported phonological observations of Cordia 
dichotoma (Ehretiaceae) on leaf- fall, new foliage, flowering and fruiting.(37) 
Cordia myxa 
Shraddhasuman et al., (2009) have reported Cordia myxa (Boraginaceae) bark 
mixed with water and filtered is given in chronic fever(38) 
                                                                                                   Review of Literature 
 
Department of Pharmacognosy, MMC Page 20 
 
MG. Rajesh et al., (2000) have reported ten cirrhotic patients were given kamilari 
(one tab 850 mg, 3 times daily) for 4 months and biochemical parameters analysed in serum. 
Levels of serum enzymes, cholesterol and billirubin are decreased and that of proteins 
increased. It can be concluded that kamilari is a hepatoprotective drug composing of Cordia 
myxa. (39) 
Cordia mutispicata 
M. Das Gracas et al., (2010) have reported the essential oils obtained from five 
samples of Cordia multispicata collected in four municipalities of the state of Par (Brazil) by 
hydro distillation method and analysed by GC/FID and GC-MS. (40) 
T.B. Correia Desilva et al., (2010) have reported the total phenolic content and 
antioxidant activity of extracts and four flavonoids isolated from the leaves of two 
boraginaceae species Cordia multispicata and Tournefortia bicolor which were evaluated 
using folin-ciocalteu reagent, DPPH free radical scavenging and inhibition of peroxidation of 
linoleic acid by FTC method.(41) 
Cordia globosa 
JP. David  et al ., ( 2007) have reported that the Cordia globosa extract from the 
Brazilian northeastern semi-acid region , were evaluated through DPPH assays β-carotene 
bleaching & brine shrimp lethality tests.(42) 
S. Jane Eire S et al., ( 2006) have reported the chemical composition of the essential 
oils obtained from the fresh leaves of Cordia globosa (Boraginaceae) at different ontogenetic 
stages and which were analysed by GC/ GCMS.(43) 
 
                                                                                                   Review of Literature 
 
Department of Pharmacognosy, MMC Page 21 
 
Cordia latifolia 
B.S. Siddiqui B.S et al., (2010) have isolated 3 new natural constituents from the 
fruits & leaves of Cordia latifolia.(44) 
Cordia lucocephala 
Jaecio Carlos Diniz et al., (2008) have isolated essential oil from the leaves of 
Cordia lucocephala by hydro distillation method which was subsequently analysed by 
GC/MS &GC-FID. (45) 
Cordia linnaei 
JR. Loset et al., (1998) have isolated 3 new meroterpenoid naphthoquinones, the 
known cordia quinine B & a new naphthoxirene from the roots of Cordia linnaei. The 
naphthoquinones showed activity against cladosporium cucumerinum, candida albicans & the 
larvae of the yellow fever transmitting mosquito Aedes aegypti.(46) 
Cordia fragrantissima 
K. Mori  et al., (2008) have reported that the methanolic extract of the wood of 
Cordia fragrantissima exhibit significant activity against leishmania (47)  
Cordia americana 
GF. Mourasss-Costa GF et al., (2012) have reported that the extract of Cordia 
americana is  most effective against herpes simplex virus type 1.(48)  
Cordia curassavica 
Tzasna Hernandez et al., (2007) have reported the anti microbial activity of Cordia 
curassavica  against 13 bacteria & 5 fungal strains..(49) 
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Cordia spinenscens 
Yasmina Auralim et al., (1997) have reported that the aqueous extract of Cordia 
spinenscens leaves contains magnesium lithospermato, calcium rosmarinate & magnesium 
rosmarinate and which act as potent inhibitory substances against HIV-1 reverse 
transcriptase.(50) 
Cordia salicifolia 
Matsunaga et al., (1997) have reported that the ethyl acetate extract of Cordia 
salicifolia showed potential negative inotropic effect on the isolated left atrium. (51) 
Cordia trichotoma 
S.A. Jane Eire et al., (2005) have isolated essential oils from the heart wood and sapwood of 
Cordia trichotoma (Boraginaceae)  and whichwere analysed by GC/FID and GC/MS. (52) 
Cordia gelletii 
P.N. Okusa et al., (2007) have reported that the methanolic extract of root bark of 
Cordia gelletii were used for the treatment of various disorders, including malaria, diarrhoea, 
wounds and skin diseases and these activities may be due to antimicrobial and antioxidant 
properties.(53) 
Cordia globifera 
Dettrakul.S et al.,(2009) have isolated cordial globiferin from the root extracts of 
Cordia globifera. Antimalarial, antifungal and cytotoxic activities were also evaluated. (54) 
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CHAPTER - III 
AIM AND SCOPE OF THE STUDY 
Plants have been used for healing purpose and form the origin of much of the modern 
medicine. Many medicinally important drugs originate from plant sources. The production of 
drugs from plants continues and many pharmaceutical companies engaged in large- scale 
pharmacological screening of herbs. 
Cordia obliqua willd. is an important medicinal plant, belonging to the family 
Boraginaceae. It is a small deciduous tree, having ovate leaves and white flowers (55). 
The ethnomedical information states that almost all parts of this tree are employed for 
a number of disorders. 
The leaves are useful in ulcers and in headache. The juice of the bark along with 
coconut oil is given in gripes. The barks and also the unripe fruit are used as a mild tonic.  
Fruits are used as anthelmintics, astringent, demulcent, diuretic, expectorant in bronchial 
affections, irritation of urinary passages. The kernals are a good remedy in ringworm. The 
santals use the powder of the bark as an external application in prurigo. The Javanese use the 
bark in fever (56). 
The Phytochemical studies of Cordia obliqua willd. have revealed the presence of  
steroids, alkaloids, triterpenes, phenolic compounds, flavonoids and reducing sugars (57). 
Based on the above information and studies available, the present research work has been 
framed to carry out the following studies on the leaves of Cordia obliqua wild. 
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1. Pharmacognostical studies 
Morphological evaluation 
Microscopical analysis 
Physio- chemical parameters 
Leaf constants 
2. Phytochemical studies 
PreliminaryPhytochemical screening 
Fluorescence analysis of powder 
Quantitative estimation of phytoconstituents 
Chromatography (TLC, HPTLC) method 
3. Pharmacological studies 
 Anti- oxidant activity by invitro methods such as 
•DPPH assay   
•Ferric reducing antioxidant power assay 
•Phosphomolybdenum method 
•Nitric oxide scavenging activity 
•Reducing power assay 
Anti- inflammatory activity by invivo method – Carrageenan induced paw oedema method. 
Anti- bacterial activity using organisms such as staphylococcus aureus, streptococcus alpus, 
pseudomonas, E.coli. 
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CHAPTER – IV 
PHARMACOGNOSTIC STUDIES 
SECTION – A 
GENERAL DESCRIPTION OF THE PLANT 
Cordia obliqua willd.is a medium sized deciduous tree with moderately broad branches. 
Botanical  source  :Cordia obliqua 
Family                        : Boraginaceae 
Synonyms                  : Cordia wallichii G. Don., 
: Cordia myxa Linn.,        
: Cordia latifolia Roxb. 
Common  name   : Clammy cherry, Mookuchalipazham 
Vernacular  names 
English           - Large sebesten 
Hindi              - Baralessura 
Sanskrit          - Bhukarvudara 
Kanada          - Chellamara, nakkera 
Malayalam    - Pasakamaram, 
Telugu           - Nakkera 
Tamil              - Naruvili 
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Taxonomic classification (58) 
Kingdom        - Plantae 
Subkingdom  -Tracheobionta 
Super division - Spermatophyta 
Division        - Magnoliophyta 
Sub class       - Asteridae 
Order            - Lamiales 
Family           - Boraginaceae 
Genus           - Cordia 
Species         - obliqua 
 
Geographical Distribution ( Habitat ) (Fig. 5) 
Widely spread over the whole of the warmer parts of India and Ceylon (often 
cultivated). Malacca-Indo-china, Hainan, Formosa, Java, Phillipines, New Guinea, Australia 
(58).  Common throughout India, particularly in the western region (59). 
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Description 
Tree  
Cordia obliqua Willd. is a medium sized tree,10.5m  high, found scattered throughout the 
mid- Himalayas up to elevations of 1,470 meters.  
There are two forms of cordia obliqua willd., occurring in Himachal Pradesh. The major 
difference between these two is the size of the fruits, which is small in one case and large in 
the other. The present observations were recorded only on the small- fruited type which is 
common. 
Leaves (Fig.6) 
Leaves are alternate, ovate, 10.1cm long, 5.7cm broad, entire to slightly dentate with  
pinnately- reticulate venation.Young leaves are tomentosefrom  beneath and the matured 
leaves are glabrous, but more or less rough when full grown. Sometimes,  variable in shape 
from elliptic lanceolate to broad ovate, often with a rounded or cordate base, basal nerves 
3,rarely5,blade 3-6, petioles 2.5-5cm long. 
Flowers (Fig.8) 
Flowers are small and the average diameter of a fully open flower, 6mm, very short 
stalked, bisexual, white in colour. Inflorescence,terminal or an axillary cyme almost 
resembling a biparous cyme. Flowers per cluster,14. Calyx is cup shaped and gamosepalous, 
4mm, green. Corolla, creamish white, polypetalous with 4 petals , 6mm. stamens 2in number, 
epipetalous with a very small filament. Gynoecium has a globose ovary and bifurcated.    
Flowers from March- April and fruits from May-June. 
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Fruits (Fig.7) 
Fruit is a drupe, 1.75cm in diameter, light yellow to slightly greenish in colour, with a 
light-red tinge at the time of full maturity; epicarp, thick; mesocarp, mucilaginous; endocarp, 
hard and stony. 
Bark 
Bark is dark greyish brown in colour, surface is rough with transverse and 
longitudinal cracks and fissures,inner surface deep greyish;  fractured surface horny; taste and 
odour indistinct. 
Parts used 
Fruits, leaves and bark are used medicinally. 
Collection of plant 
The plant  of Cordia obliqua willd. was collected from the Madurai medical college 
campus, Madurai and it was authenticated by Taxonomist. The leaves were washed 
thoroughly and dried in shade  (Fig.4) 
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SECTION – B 
MICROSCOPICAL EVALUATION OF THE LEAVES (60-71) 
 The leaves of the plant were subjected to microscopical evaluation. The samples of 
leaves were cut and removed from the plant and fixed in FAA (formalin, 5ml; acetic acid, 
5ml; ethyl alcohol, 90ml). After 24h of fixing, the specimens were dehydrated with graded 
series of t-butyl alcohol . Infiltration of the specimens was carried by gradual addition of 
paraffin wax (M.Pt-58-60oC) until TBA solution attained super saturation. The specimens 
were cast into paraffin blocks.  
Sectioning  
 The paraffin embedded specimens were sectioned with the help of rotary microtome. 
The thickness of the sections was 10-12µm. De-waxing of the sections was carried out by 
customary procedure. The sections were stained with toluidine blue since it is a 
polychromatic stain. The staining results were remarkably good and some cytochemical 
reactions were also obtained. The dye rendered pink color to the cellulose walls, blue to the 
lignified cells, violet to the mucilage and blue to the protein bodies and also stained with 
safranin.  
Leaf clearing 
Two methods were used for studying the stomatal morphology, venation pattern and 
trichome distribution. Paraffin embedded leaf was used for para-dermal sections. From these 
sections, the epidermal layers as well as vein islets were studied. Another method employed 
was clearing leaf fragments by immersing the material in alcohol (to remove chlorophyll) 
followed by treating with 5% sodium hydroxide. The material was rendered transparent due 
to loss of cell contents. Epidermal peeling by partial maceration employing Jeffrey’s 
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maceration was also done. Glycerin mounted temporary preparations were made for cleared 
materials.   
For the study of elements of xylem, small fragments of leaves were macerated with 
Jeffery’s maceration fluid.  
Powdered materials of different parts were cleared with sodium hydroxide and 
mounted in glycerin medium after staining. Different cell components were studied and 
measured. 
Photomicrographs 
The photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observations bright field was used and for the study of starch 
grains and lignified cells, polarized light was employed. Since these structures have 
birefringent property, under polarized they appear bright against dark background. The 
magnifications of the anatomical features are indicated by the scale-bars in the photographs.  
The microscopic features of the leaf of the tree were presented in Fig.9 to14 
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MICROSCOPICAL STUDY OF THE LEAVES 
Anatomy of the leaf 
The transverse section of the leaf shows the following anatomical features 
Leaf  (Fig.9: 1,2) 
 The leaf is dorsiventral, xeromorphic and hypostomatic. The midrib is thick and wide 
and plano-convex in sectional view; the adaxial side is flat and the abaxial part is 
semicircular (Fig.9.1). It is 900µm thick and 850µm wide. The epidermal layer is thin and the 
cells are spindle shaped, thick walled and darkly stained. The ground tissue around the 
vascular strand is parenchymatous; the cells are circular, thick walled and compact. 
 The structure of the vascular system is complex. It consists of abaxial wide, shallow 
bowl shaped vascular strand and two smaller adaxial vascular strands (Fig.9.2). The abaxial 
vascular strand consists of several solitary, diffusely distributed xylem elements and thick 
walled lignified fibres. Along the lower part of the xylem strand, occur several discrete 
phloem masses. (Fig.9.2) The adaxial vascular strands are collateral having a few rows of 
xylem elements and phloem on the centre part of the xylem. The adaxial and abaxial vascular 
strands are surrounded by a thick sclerenchyma shealth. 
Lamina  (Fig.10.1) 
 The lamina exhibits dorsiventral symmetry. The adaxial epidermis is fairly thick 
walled; the cells cylindrical and have prominent cuticle. The abaxial epidermis has smaller, 
thin walled cells. The epidermis is stomatiferous (Fig.10.1). 
 The mesophyll tissue is differentiated into adaxial band of palisade cells and abaxial 
zone of spongy parenchyma cells. The palisade cells are thin, elongated compact and 
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chlorophyllous. The spongy parenchyma cells are spherical and lobed forming wide air- 
spaces (Fig.10.1). The lamina is 200µm thick. The palisade cells are 80µm in height. 
Crystals (Fig.10.2) 
 Two types of crystals are seen in the leaf. 
1. Calcium carbonate crystals are located in specially modified epidermal cells of the 
leaf (Fig. 10.1). The epidermal cells are lightly dilated into circular (spherical) cells 
called lithocysts; with in the lithocysts occur cystolith with a short stalk attached on 
the epidermal cell wall.  
2. Calcium oxalate crystals are large granular bodies located in the ground parenchyma 
of the midrib and mesophyll cells (Fig.10.2). 
Venation pattern (Fig. 11. 1 & 2) 
 The veins and veinlets are thick and straight. The vein- islets are narrow, squarish or 
polyhedral in outline. The vein boundary is thick. The vein -termination are short and thick. 
They are simple, forked once or twice (Fig.11.2). 
Epidermal trichomes (Fig 12.1) 
  Unique types of epidermal trichomes are frequently seen on the abaxial epidermis. 
The trichome is nonglandular type. It consists of bulbous basal part measuring 80µm thick. 
The terminal part is sharp, pointed and thin. The trichome is 140µm long. It arises from 
epidermal pit. The surface of the trichome has echinate out growths. 
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Stomata 
  Stomata occur on the abaxial epidermis only. The stomata are actinocytic, having 
three or four radiating subsidiary cells (Fig.13.2 & 14.1,2). The epidermal cells are thick 
walled; the anticlinal walls slightly wavy. The stomata are 20 × 30µm in sizes. 
The adaxial epidermis is apostomatic. The cells are polygonal with straight anticlinal walls 
(Fig. 14.1 & 2). There are circular, shallow cavities on the epidermis from which the 
epidermal trichomes arises (Fig 14.1) 
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SECTION -C 
QUANTITATIVE ANALYTICAL MICROSCOPY [72] 
Quantitative analytical microscopy is useful for measuring the cell contents of the 
crude drugs, which help in their identification, characterization, and standardization. A clear 
idea about the identity and characteristic features of the drug can be obtained after several 
numbers of determinations; the characteristics number obtained was noted and compared 
with a standard value to find out whether it is within the range.   
Determination of stomatal number and stomatal index 
Stomatal number: The average number of stomata/sq.mm area of each surface of a leaf 
epidermisis termed as stomatal number (73).   
Stomatal index: The stomatal index is the percentage which the number of stomata formed 
to the total number of epidermal cells, each stoma being counted as one cell. 
To study the stomatal morphology (type of stomata), stomatal number and stomatal 
index of leaf, the leaf was subjected to epidermal peeling.  
Procedure (73) 
The leaf was cleared by boiling with chloral hydrate solution or alternatively with 
chlorinated soda. The upper and lower epidermis was peeled out separately by means of 
forceps. The cleared leaf was placed on a slide and mounted in glycerin. A camera lucida and 
drawing board was placed and a stage micrometer was inserted for making the drawing scale. 
A square of 1mm was drawn by means of stage micrometer. The slide with cleared leaf 
(epidermis) was placed on the stage of the microscope and examined under 45X objective 
and 10X eye piece. The epidermal cell and stomata was traced. The numbers of stomata 
present in the area of 1sq. mm. including the cell if at least half of its area lies within the 
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square was counted. The result for each field was calculated and the average number of 
stomata per sq. mm was determined and their values were tabulated in Table3. 
For stomatal index, the glycerin mounted leaf peeling as mentioned above was made 
and circle (O) like mark for each stomata and a cross (X) like mark for each epidermal cells 
was marked on the chart paper. The stomatal index was calculated by using the formula,  
 Stomatal index = S/(E + S) x 100, where S was the number of stomata in 1sq mm area 
of leaf and E was the number of epidermal cells (including stomata) in the same area of leaf. 
The values were tabulated in Table 4. 
Table:3: Stomatal number of the leaves of Cordia  obliqua willd. 
OBSERVATION NUMBER LOWER EPIDEMIS 
1 57 
2 68 
3 62 
4 64 
5 79 
6 53 
7 59 
8 63 
9 65 
10 55 
MINIMIUM 53 
AVERAGE 62.5 
MAXIMUM 79 
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Table:4: Stomatal index of the leaf of Cordia obliqua willd. 
OBSERVATION NUMBER LOWER EPIDERMIS 
1 54.63 
2 47.59 
3 56.87 
4 46.85 
5 45.73 
6 52.94 
7 46.73 
8 50.48 
9 49.52 
10 58.94 
MINIMUM 45.73 
AVERAGE 48.41 
MAXIMUM 58.94 
 
Determination of Vein Islets and Vein Terminations 
The term vein islet is used to denote the minute area of photosynthetic tissue encircled 
by the ultimate divisions of conducting strands. The number of vein islet/sq.mm of leaf 
fragments is known as vein islet number. An ultimate free end or termination of a veinlet is 
termed as veinlet termination. The number of vein terminals present in one sq.mm area of 
leaf fragment is termed as veinlet termination number (75). 
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Procedure (74) 
The fragment of leaf lamina with an area of not less than 1sq.mm excluding the 
midrib and the margin of the leaf was taken. The fragments of leaf lamina were cleared by 
heating in a test tube containing chloral hydrate solution on a boiling water bath until clear. 
The cleared fragments were stained with saffranin solution and a temporary mount was 
prepared with glycerol solution. The stage micrometer placed on the microscopic stage, 
examined under 10X objective and 6X eye piece and an area of 1 sq mm square was drawn. 
The cleared leaf piece was placed on the microscope stage, the vein islets and vein terminals 
included in the square was drawn. The number of vein islets and terminals within the square 
were counted. The results obtained for the number of vein islets and terminals in1sq mm were 
tabulated in Table 5. 
                                                                                            Pharmacognostical Studies 
 
Department of Pharmacognosy, MMC Page 38 
 
Table:5: Vein islet and vein termination number of Cordia  obliqua willd. 
OBSERVATION NUMBER VEIN ISLET NUMBER VEIN TERMINATION 
1 23 27 
2 25 33 
3 18 25 
4 13 29 
5 17 31 
6 11 19 
7 9 39 
8 16 37 
9 10 28 
10 27 21 
RANGE   
MINIMUM 9 19 
AVERAGE 16.9 28.9 
MAXIMUM 27 39 
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SECTION – D 
PHYSICAL PARAMETERS 
Determination of Ash values (75,76)   
Ash Content    
The residue remaining after incineration of the drug is the ash content of crude drug, 
which simply represents inorganic salts naturally occurring in the drug or adhering to it or 
deliberately added to it as a form of adulteration. The total ash, acid insoluble ash and water 
soluble ash are generally determined. 
Procedure 
Determination of Total Ash 
 An accurately weighed 2g of air dried powdered drug was taken in a tarred silica 
crucible and incinerated at a temperature not exceeding 450oC, upto 6hrs until free from 
carbon then allowed to cool and weighed. The percentage of ash was calculated with 
reference to the air dried drug.   
Determination of Acid Insoluble Ash 
The total ash obtained from the previous procedure was mixed with 25ml of 2M 
hydrochloric acid and boiled for 5min in a water bath, and then the insoluble matter was 
collected in an ashless filter paper (Whatmann) and washed with hot water, dried and ignited 
for 15min at a temperature not exceeding 450oC, cooled in a dessicator and weighed. The 
percentage of acid insoluble ash was calculated with reference to the air dried drug.     
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Determination of Water Soluble Ash 
The total ash obtained from the previous procedure was mixed with 25ml of water and 
boiled for 5min in a water bath, and then the insoluble matter was collected in an ashless 
filter paper and washed with hot water, dried and ignited for 15min at a temperature not 
exceeding 450oC, cooled in a dessicator and weighed. The insoluble matter was subtracted 
from the weight of the total ash; the difference in weight represents the water soluble ash. 
The percentage of water soluble ash was calculated with reference to the air dried drug. 
Determination of sulphated ash (77) 
An accurately weighed 2g of air dried powdered drug was taken in a tarred silica 
crucible which was previously ignited and cooled before weighing at a temperature not 
exceeding 450°C. The residue was moistened with 1ml of concentrated sulphuric acid, 
ignited at 800 ± 25°C until all black particles have disappeared. It was then cooled; again 
sulphuric acid was added and ignited. It was cooled and the percentage of sulphated ash was 
calculated with reference to air dried drug. 
The values in respect of the total ash values, acid insoluble ash and water soluble ash 
and sulphated ash value were tabulated in Table 6 . 
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Table:6: Ash values of the leaves of Cordia  obliqua  willd. 
OBSERVATION 
NUMBER 
TOTAL 
ASH% 
ACID 
INSOLUBLE 
ASH% 
WATER 
SOLUBLE 
ASH% 
SULPHATED 
ASH% 
1 
2 
3 
4 
5 
6 
 
10.5 
12 
11.5 
9.5 
11.5 
8.86 
 
0.84 
0.90 
0.90 
 
 
 
0.94 
0.94 
0.90 
 
0.89 
0.85 
0.90 
MINIMUM 8.86 0.84 0.90 0.85 
AVERAGE 10.64 0.88 0.92 0.88 
MAXIMUM 
 
12 0.90 0.94 0.90 
 
Loss on drying (75, 76) 
The method described by Wallis was followed for the determination of loss on drying.  
            One gram of the powdered leaf was accurately weighed in a tarred dish and dried in 
an oven at 105ºc for one hour. It was cooled in a dessicator and again weighed. The loss on 
drying was calculated with reference to the amount of dried powder taken and presented in 
Table. 7 
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Table:7: Percentage of loss on drying 
Observation number Loss on drying (%) w/w 
1 9.35 
2 9.32 
3 10.09 
4 9.82 
5 9.43 
6 10.10 
Minimum 9.32 
Average 11.23 
Maximum 10.10 
 
Determination of Extractive Values  
The extractive values are the important factor to determine the amount of active 
principle or phytocostituents present in the plant materials, when extracted with suitable 
solvents. The extraction of crude plant materials with various solvents gives a solution 
containing different phytoconstituents. Composition of the phytoconstituents in a particular 
solvent depends upon the nature of drugs and solvents used. This is an important tool for the 
analysis of crude plant materials for its identity, purity and quality. 
Procedure 
Determination of ethanol soluble extractive 
             An accurately weighed 5g of the air dried coarsely powdered drug was macerated 
with 100ml of ethanol in a closed flask for 24h, shaking frequently during the first 6hours and 
allowed to stand for 18hours. Thereafter filtered rapidly, taking precautions against loss of 
ethanol. Then evaporate 25ml of the filtrate to dryness in a tarred china dish  at 105oC and 
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weighed. The percentage of ethanol soluble extractive was calculated with reference to the air 
dried drug. 
Determination of ethyl acetate soluble extractive:     
The procedure adopted under ethanol soluble extractive was followed using ethyl 
acetate as a solvent. 
Determination of chloroform soluble extractive: 
The procedure adopted under ethanol soluble extractive was followed using 
chloroform as a solvent. 
Determination of petroleum ether soluble extractive:     
The procedure adopted under ethanol soluble extractive was followed using petroleum 
ether as a solvent. 
Determination of acetone soluble extractive: 
The procedure adopted under acetone soluble extractive was followed using acetone as a 
solvent 
Determination of water soluble extractive:      
An accurately weighed 5g of the air dried coarsely powdered drug was macerated 
with 100ml of chloroform water in a closed flask for 24hours, shaking frequently during the 
first 6hours and allowed to stand for 18hours. Thereafter filtered rapidly, taking precautions 
against loss of chloroform water. Then evaporate 25ml of the filtrate to dryness in a tarred 
china dish at105oC and weighed. The percentage of water soluble extractive was calculated 
with reference to the air dried drug.  
The extractive values obtained for different solvents were presented in table 8. 
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Table:8: Extractive values of Cordia  obliqua willd. 
 
S.No 
Solvents Used (Increasing 
order of polarity) 
Extractive Value 
(% w/w) 
1 Petroleum ether 16.79 
2 Ethyl acetate 1.19 
3 Chloroform 2.95 
4 Ethanol 2.67 
5 Acetone 1.59 
6 Water 18.22 
 
Determination of Foaming Index ( 75) 
 Some plant materials when shaken with water cause persistent foam which may be 
attributed to the presence of saponins in that material. The foaming ability of an aqueous 
solution of plant materials and their extracts is measured in terms of foaming index.  
Procedure 
 An accurate quantity of about 1g of the coarse plant material was weighed and 
transferred into an Erlenmeyer flask containing 100ml of boiling water. The flask was boiled 
at moderate heat for 30min. The solution was cooled and filtered into a 100ml volumetric 
flask and sufficient distilled water was added to make up the volume. The solution was 
poured into ten stoppered test tubes in successive portions of 1ml, 2ml, etc. upto 10ml and the 
volume of the liquid in each tube was adjusted with water upto 10ml. The tubes were then 
stoppered and shaken in a length wise motion for 15sec (two shakes/sec) and allowed to stand 
for 15min. The height of foam was measured.  If the height of the foam in every tube was less 
than 1cm, the foaming index was less than 100. If the height of the foam, 1cm was measured 
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in any test tube, the volume of the plant material decoction in this tube (A) was used to 
determine the index.  If the height of the foam was more than 1cm in every tube, the foaming 
index was over 1000. In this case, the determination was repeated using a new series dilution 
of the decoction in order to obtain a result. The foaming index was calculated by using the 
following formula 1000/A where A was the volume in ml of the decoction used for preparing 
the dilution in the tube where foaming to a height of 1cm was observed. The results obtained 
was presented in table 9. 
Determination of Swelling Index (76) 
 Swelling index is the volume in ml taken up by the swelling of plant material under 
specified conditions. The medicinal plant materials like gums, mucilage, and pectin have 
swelling property. 
Method  
 An accurately weighed 1g of the powdered drug material was taken in the 25ml glass 
stoppered measuring cylinder. 25ml of water was added and shaken the mixture thoroughly 
every 10min for 1h. Then, allowed to stand for 3hrs at room temperature. The volume in ml 
occupied by the plant material was measured, including sticky mucilage. The results obtained 
were presented in table 9. 
Table: 9: Foaming and swelling index of Cordia obliqua willd. 
Content  
Foaming index < 100 
Swelling index    3.66±0.81 
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SECTION – E 
POWDER MICROSCOPY 
i). Fluorescence analysis  
The fluorescent analysis of the plant extracts of Cordia obliqua was carried out by 
using the method of Chase and Pratt (1949) (78). The observations were tabulated in Table10 
 Table:10: Fluorescence analysis of extracts of Cordia obliqua willd. 
Extracts 
Colour in Day 
light 
Colour under UV 
Lamp 254nm 
Colour under 
UV Lamp 
365nm 
Colour in 
visible 
Acetone Dark green Dark green Orange Dark green 
Ethanol Green Green Orange Light green 
Ethyl acetate Dark green Green Orange Light green 
Chloroform Green Green Orange Puff colour 
Petroleum ether Brown Light green Brown Brown 
Water Brown Green Honey colour Brown 
 
ii) Powder microscopy of the leaf of Cordia  obliqua willd. 
       The powder microscopy of leaves shows the following characters. 
 Lignified sclerenchyma cells  
 Calcium oxalate crystals 
 Epidermal cells with actinocytic stomata  
 Trichome is nonglandular type bulbous basal part, sharp, thin pointed. 
 Starch grains  
 Fragments of spongy paranchyma cells. 
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CHAPTER –V 
PHYTOCHEMICAL EVALUATION 
SECTION – A 
ORGANOLEPTIC EVALUATION 
Nature – Coarse powder 
Colour – Light Green colour 
Odour– Characteristic odour 
Taste – Characteristic taste 
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SECTION – B 
PRELIMINARY PHYTOCHEMICAL SCREENING 
Phytochemistry is widely used in the field of herbal medicine. Phytochemical 
characterization of plant material is important as it relates to the therapeutic actions. It is 
perhaps obvious that different species of plants would have different chemical constituents. 
However these differences can extent to different varieties or even the same varieties grow in 
different location or harvested at a different time, different parts of plant such as leaves, bark, 
seed, root, flowers and pods can also have different active constituents (79). 
MATERIALS AND METHODS 
QUALITATIVE CHEMICAL TESTS FOR THE LEAF POWDER AND CRUDE 
EXTRACTS (80-82) 
Qualitative chemical tests are carried out for the purpose of specific identity of the 
substances in the crude extracts. The color reaction or precipitate usually observed by which 
we can identify a class of compound. Chemical tests can be useful for the investigation of the 
chemical compounds and to observe the efficiency of an extraction process. The petroleum 
ether, ether, ethyl acetate, methanol, ethanol and aqueous extracts were subjected to 
qualitative chemical tests. The various chemical tests performed on the extracts were for 
steroids, terpenoids, flavones, anthraquinones, sugars, glycosides, alkaloids, quinones, 
phenols, tannins and saponins and the results were recorded. 
1. Test for sterols 
The powdered leaf was first extracted with petroleum ether and evaporated to a 
residue. Then the residue was dissolved in chloroform and tested for sterols. 
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a.Salkowski’s Test: 
A few drops of concentrated sulphuric acid were added to the above solution, shaken 
well and set aside. The lower chloroform layer of the solution turns red indicating the 
presence of sterols. 
b.   Liebermann – Burchard’s Test: To the chloroform solution a few drops of acetic 
anhydride and 1ml of concentrated sulphuric acid were added through the sides of the test 
tube and set aside for a while. At the junction of two layers a brown ring appears and the 
upper layer turned green indicating the presence of sterols. 
2. Test for carbohydrates 
a. Molisch’s test: 
 To the aqueous extract and powdered drug of plants, add few drops of alcoholic – α – 
naphthol solution and sulphuric acid. A purple colour will be formed if carbohydrates are 
present. 
b.Benedict’s test: 
The aqueous extract of the powdered leaf was treated with Benedict’s reagent and 
boiled on a water bath and cooled. An reddish brown colour precipitate indicates the presence 
of carbohydrates. 
b. Fehling’s Test: 
 The aqueous extract of the powdered leaf was treated with Fehling’s solution I and II 
and heated on a boiling water bath for half an hour. A red precipitate indicates the presence of 
free reducing sugars 
3. Test for glycosides 
a.Borntrager’s  Test. 
The powdered leaf  was boiled with dilute sulphuric acid, filtered and to the filtrate 
benzene was added and shaken well. The organic layer was separated, to which ammonia 
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solution was added slowly. No pink colour in the ammoniacal layer indicates the absence of  
anthraquinone glycosides. 
Test for Cardiac Glycosides 
a.KellerKiliani Test:  
The powdered leaf was boiled with 10% alcohol for 2min, cooled and filtered. To the 
filtrate, lead sub acetate was added and filtered. The filtrate was then extracted with 
chloroform. The chloroform layer was separated and evaporated to dryness. The residue was 
dissolved in glacial acetic acid with traces of ferric chloride. To this few drops of 
sulphuricacid was added slowly along the sides of the test tube. No reddish brown ring at the 
junction and no green colour changes on standing indicates the absence of cardiac glycosides. 
b.Legal test:  
The powdered leaf  was dissolved in pyridine, sodium nitroprusside solution was 
added to it and made alkaline. No pink or red colour indicates the absence of cardiac 
glycosides. 
c.Baljet test: 
 To the powdered leaf sodium picrate solution was added. No yellow or orange colour 
indicates the absence of cardiac glycosides. 
Test for coumarin glycosides [83]  
  A small amount powdered drug was placed in a test tube and covered with a filter 
paper moistured with sodium hydroxide solution. The covered test tube was placed on 
waterbath for several minutes. Then the paper was removed and exposed to UV light. No 
green colour fluorescence was observed indicating the absence of coumarin glycoside. 
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4. Test for Proteins and free amino acids 
a.Millon’sTest : 
A small quantity of aciduous – alcoholic extract of the powdered drug was heated 
with Millon’s reagent. A white precipitate turning red on heating indicates the presence of 
proteins.  
b.Biuret Test:  
To the alcoholic extract of powdered drug, one ml of dilute sodium hydroxide(10%) 
solution was added followed by this one drop of very dilute copper sulphate solution was 
added. A violet colour indicates the presence of proteins. 
5. Test for Mucilage 
A few ml of aqueous extract was prepared from the powdered drug and treated with 
ruthenium red. A pinkish red colour indicates the presence of mucilage. 
6. Test for Flavonoids 
a.Shinoda test:  
 A little of the powdered drug was heated with alcohol and filtered. To the test 
solution magnesium turnings and few drops of concentrated hydrochloric acid were added 
and boiled for five minutes. Yellow colour indicates the presence of flavonoids. 
b.Alkali Test: 
 To the small quantity of test solution 10% aqueous sodium hydroxide Solution was 
added. A yellow orange color indicates the presence of flavonoids.  
c.Acid Test 
 To the alcoholic test solution, few drops of concentrated sulphuric acid was added. 
Yellow to orange colour was produced indicating the presence of flavonoids. 
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7.Test for terpenoids 
The powdered leaf was shaken with petroleum ether and filtered. The filtrate was 
evaporated and the residue obtained was dissolved in small amount of chloroform and to the 
chloroform solution tin and thionyl chloride were added. No pink color indicates the absence 
of terpenoids. 
8. Test for Tannins  
A small quantity of the powdered drug was extracted with water. To the aqueous 
extract, few drops of ferric chloride solution was added. A bluish black color indicates the 
presence of tannins. 
9. Test for Alkaloids 
About 2gm of the powdered material was mixed with 1gm of calcium hydroxide and 
5ml of water into a smooth paste and set aside for 5min. It was then evaporated to dryness in 
a porcelain dish on a water bath. To the residue, 20ml of chloroform was added, mixed well 
and refluxed for half an hour on a water bath. Then it was filtered and the chloroform was 
evaporated. To the residue, 5ml of dilute hydrochloric acid was added. The solution was 
divided into four parts and 2ml of each of the following reagents were added and the colour 
noted below indicates the presence of alkaloids. 
a) Mayer’s Reagent                 -    Cream precipitate produced 
b) Dragendorff’s Reagent       -     Reddish brown precipitate produced 
c) Hager’s Reagent                  -     Yellow precipitate 
d) Wagner’s Reagent              -       Reddish brown precipitate 
 
Test for purine group (Murexide test) 
The residue obtained after the evaporation of chloroform as described above was 
treated with 1ml of hydrochloric acid in a porcelain dish and 0.1gm of potassium chlorate 
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was added and evaporated to dryness on water bath. Then the residue was exposed to the 
vapour of dilute ammonia solution. No purple colour indicates the absence of purine group of 
alkaloids. 
10.Test for saponin. 
About 0.5 g of the powered material was boiled gently for 2 minutes with 20ml of 
water and filtered while hot and allowed to cool. 5 ml of the filterate was then diluted with 
water and shaken vigorously. The formation of frothing indicates the presence of saponin. 
11. Test for volatile oil 
About 100gm of fresh leaves were taken in a volatile oil estimation apparatus and 
subjected to hydro distillation for 4 hrs. No volatile oil was observed in the absence of 
volatile oil 
The above chemical tests were carried out by using leaf powder and different plant 
extracts and the results were tabulated in Tables 11&12 respectively. 
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Table 11: Preliminary phytochemical screening for the leaf powder of Cordia obliqua 
willd. 
S.NO TEST RESULTS 
1. TEST FOR STEROLS  
 a. Salkowski’s test + 
 b. Libermann- burchard’s test + 
2. TEST FOR CARBOHYDRATES  
 a. Benedict’s test + 
 b. Fehling’s test + 
3. TEST FOR PROTEINS  
 a. Biuret test + 
 b. Xanthoprotic test + 
4. TEST FOR ALKALOIDS  
 a. Mayer’s reagent + 
 b. Dragendroff’s reagent + 
 c. Hager’s reagent + 
 d. Wagner’s reagent + 
5. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides  
 i) Borntrager’s test - 
     ii) Modified Borntrager’s test - 
 b. Cardiac glycosides  
 i) Keller Killiani test  - 
     ii) Baljet test - 
6. TEST FOR SAPONINS + 
7. TEST FOR TANNINS  
 a) FeCl3 test  + 
 b) Lead acetate test + 
8. TEST FOR FLAVONOIDS  
 a. Shinoda test + 
 b.Alkali test + 
 c.Acid test  
9. TEST FOR TERPENOIDS - 
10. TEST FOR VOLATILE OILS - 
11. TEST FOR COUMARINS  
 b) Fluorescence test - 
(+) indicates positive reaction                 (-) indicates negative reaction 
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Table: 12: Preliminary Phytochemical Screening for the various extracts of leaf powder 
of Cordia obliquaWilld. 
Tests Pet ether 
Extract 
Methanol 
Extract 
Ethanol 
Extract 
Aqueous 
Extract 
1.Test for sterols     
a.Salkowski’s test + - - - 
b.Libermann-Burchard’s test + - - - 
2. Test for carbohydrates     
a. Molisch’s test - + + + 
b. Fehling’s test - + + + 
c. Benedict’s test - + + + 
3. Test for proteins     
a. Millon’s test - - + + 
b.Biuret test - - + + 
c. Ninhydrin test - - + + 
4.Test for Alkaloids     
a.Mayer’s reagent - - + - 
b. Dragendroff’sreagent - - + - 
c. Hager’s reagent - - + - 
d. Wagner’s reagent - - + - 
e. Test for purine group 
(Murexide test) - - - - 
5. Test for Glycosides 
a.Anthraquinone glycosides 
    
i) Borntrager’s test - - - - 
 ii) Modified Borntrager’s test - - - - 
b. Cardiac glycosides     
i) Keller Killiani test  - - - - 
    ii) Baljet test - - - - 
c.Cyanogenetic  glycosides - - - - 
d.Coumarin glycosides - - -  - 
6. Test for Saponins - - + + 
7. Test for tannins     
i) FeCl3 test  - - + + 
ii) Lead acetate test      - - + + 
8. Test for Flavanoids     
a. Shinoda test - + + + 
b.Alkali test - + + + 
c.Acid Test - + + + 
9. Test for Terpenoids - - - -- 
10. Test for Volatile Oils - - - - 
11. Test for Mucilage  - - - + 
(+) indicates positive reaction                 (-) indicates negative reaction 
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The ethanolic extract of Cordia obliqua showed the presence of alkaloids, flavones, 
carbohydrates, phenols, tannins, saponins and proteins. The petroleum ether extract showed 
the presence of sterols. None of the extracts showed the presence of anthraquinones and 
terpenoids. 
SECTION -C 
QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
The medicinal value of the plants lies in the bioactive phytochemical constituents that 
produce definite physiological effect on human body (84) These natural compound formed the 
base of modern drugs as we use today (85).  Phytoconstituents are the natural bioactive 
compounds found in plants. These phytoconstituents work with nutrients and fibres to form 
an integrated part of defense system against various diseases and stress conditions (86). The 
most important of these bioactive constituents of plants are tannins, flavonoids, Phenolic 
compounds(87,88). Flavonoids, a group of polyphenolic compounds with known properties 
such as free radical scavenging activity, inhibition of hydrolytic and oxidative enzyme and 
anti- inflammatory action (89,90). 
1. Determination of total phenolic content (91-93) 
Principle 
 The total phenol content of Cordia  obliqua, was determined by the Folin-Ciocalteu 
colorimetric method (91). The FolinCiocalteu reagent is a mixture of phosphomolybdate and 
phosphotungstate. The method measures the amount of substance needed to inhibit the 
oxidation of the reagent (92).  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
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Reagents 
 10% sodium carbonate 
 1N Folin-Ciocalteu reagent ( Reagent diluted with equal volume of water ) 
Procedure 
  The compound gallic acid was used as standard (93) and was weighed and dissolved in 
distilled water to produce 1mg/ml stock solution. The stock solution was further diluted to get 
concentrations ranging from 2-10µg/ml. To these solutions, 0.5ml of Folin-Ciocalteu reagent 
and 0.5ml of sodium carbonate was added and the final volume was made up to 10ml with 
distilled water. The absorbance was measured at 760nm after incubation at room temperature 
for 30min. The ethanolic extract (0.5ml & 1ml of 1mg/ml) was mixed with 0.5ml of Folin-
Ciocalteu reagent and 0.5ml of 10℅ sodium carbonate and final volume was made up to 10ml 
with distilled water, and the absorbance was measured at 760nm after incubation at room 
temperature for 30min. A calibration curve was constructed by plotting concentration versus 
absorbance of gallic acid (Fig.15). A linear regression equation was formed and the amount 
of phenolic compounds was determined by using the equation.  The total phenolic content 
was expressed as mg gallic acid equivalents (GAE)/g of extract. The results were tabulated in 
Table 13. 
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Table: 13:  Estimation of total phenolic content of ethanolic extract of Cordia obliqua 
willd. 
 
S. No. 
Conc. 
of gallic 
acid in 
µg/ml 
Absorbance at 
760nm 
Conc. of 
ethanolic 
extract in 
µg/ml 
Absorbance 
at 760nm* 
Amount of total 
phenolic content 
in terms 
mgGAE/g of 
extract* 
1 2 0.229 ± 0.010 50 0.310±0.00 54.24± 0.54 
2 4 0.452 ± 0.006 100 10.746±0.01 64.70± 1.50 
3 6 0.695 ± 0.005  
Average 59.47 ± 1.02 4 8 0.918 ± 0.031  
5 10 1.162 ± 0.028  
                                          * mean of three readings ±SEM 
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Fig:15: Calibration curve of gallic acid 
 
 
 
The linear regression equation was found to be y = 0.116x-0.004 while the correlation 
was found to be 0.9998. The amount of phenolic content present in the extract in terms of mg 
GAE/g of extract was found to be   59.47 ±1.02 by using the above linear regression 
equation. 
Determination of total flavonoid content (94-95) 
Principle 
The aluminum chloride colorimetric technique was used for the estimation of total 
flavonoid estimation (94). Aluminum ions form stable complexes with C4 keto group and 
either C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It also forms 
acid labile complexes with ortho hydroxyl groups in the A or B rings of flavonoids (95). These 
complexes showed a strong absorption at 415nm which is used for the estimation of 
flavonoids.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
 
Calibration curve of gallic acid
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Reagents  
10% aluminum chloride 
1M potassium acetate 
Procedure 
A known quantity of quercetin (96)was dissolved in ethanol to get a stock solution of 
1mg/ml. Further dilutions were made to get concentrations ranging from 20-100µg/ml. 1ml 
of the above standard solutions were taken in different volumetric flasks, 0.1ml of aluminum 
chloride solution, 0.1ml of potassium acetate solution and 2.8ml of ethanol were added and 
the final volume was then made up to 5ml with distilled water. After 20min the absorbance 
was measured at 415nm. A sample without aluminium chloride was used as a blank. From 
the absorbance obtained, a calibration curve was constructed by plotting concentration versus 
absorbance of quercetin (Fig.16). 0.5ml and 1ml of ethanolic extract of Cordia obliqua at a 
concentration of 1mg/ml were taken and the reaction was carried out as above and the 
absorbance was measured at 415nm after 20min and the readings were tabulated in Table14. 
The amount of flavonoids present can be determined by linear regression analysis. The total 
flavonoid content was expressed as mg querecetin equivalents /g of extract. 
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Calibration curve of quercetin
y = 0.0307x - 0.0432
R2 = 0.9974
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Table: 14: Estimation of total flavonoid content of ethanolic extract of Cordia obliqua  
S. No. 
Conc. of 
quercetin 
in µg/mL 
Absorbance 
at 415nm 
Conc. of 
ethanolic 
extract in 
µg/ml 
Absorbanc
e at 415nm 
Amt of total flavonoid 
content in terms mg 
quercetin equivalent/ 
g of extract 
1 20 0.589 ± 0.01 100 0.196 ± 0.00 162.99±0.75 
2 40 1.151 ± 0.04 200 0.403± 0.00 144.90±1.66 
3 60 1.710 ± 0.09  
Average 153.94±1.20 4 80 2.390 ± 0.03  
5 100 3.112 ± 0.03  
*mean of three readings ± SEM 
 
Fig.16 :  Calibration curve of quercetin 
 
 
 
 
 
The linear regression equation was found to be y = 0.0307x-0.0432, while the 
correlation was found to be 0.9974. The amount of flavonoid content present in the ethanolic 
extract of Cordia obliqua in terms mg quercetin equivalent/g of extract was found to be 
153.94 ± 1.20 mg/g of extract by using the above linear regression equation. 
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Determination of total tannin content (96-98) 
Principle 
 Total tannin content of ethanolic extract of Cordia obliqua was determined by Folin 
Denis reagent method (97). Tannin like compounds reduces phosphotungstomolybdic acid in 
alkaline solution to produce a highly blue coloured solution (98). The intensity is measured 
spectrophotometerically at 700nm 
Reagents 
a) Folin Denis Reagent ( sodium tungstate 100g and phosphomolybdic acid 20gm 
were dissolved in distilled water 750ml along with phosphoric acid 50ml. The 
mixture was refluxed for 2 hrs and the volume was madeupto 1 litre with 
distilled water )  
b) Sodium carbonate solution (10%) 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Procedure 
 0.1ml,0.2ml& 0.4ml of (1mg/ml) ethanolic extracts of Cordia obliqua was taken in a 
separate test tubes and mixed with distilled water to made upto the volume of 1ml. Then add 
0.5ml of Folin Denis reagent and allowed to stand for 15 mins, then 1ml of 10% 
sodiumcarbonate solution was added and  the mixture was mixed with distilled water and 
made upto 10ml, allowed to stand for 30mins at room temperature and the tannin content was 
determined spectrophotometrically at 700nm.  
The calibration curve was generated by preparing tannic acid at different 
concentration (4, 8, 12, 16, 20µg/ml). The reaction mixture without sample was used as 
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y = 0.0224x + 0.0038 
R² = 0.9997 
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Conc. in mcg/mL 
Calibration curve for tannic acid 
blank. The total tannin content in the ethanolic extract of Cordia obliqua was expressed as 
milligrams of tannic acid equivalent per gm of extract. 
Total tannin content 
The results for total flavonoid content of 70% ethanolic extract of Cordia obliqua 
were presented in Table15. 
Table: 15:  Estimation of total tannins content of ethanolic extract of Cordia obliqua 
S. No. 
Conc. of 
quercetin 
in µg/mL 
Absorbanc
e at 415nm 
Conc. of 
ethanoli
c 
extract 
in µg/ml
Absorbance 
at 700nm 
Amt of total tannin 
content in terms mg 
tannic acid equivalent/ 
g of extract 
1 40 0.098±0.02 10 0.031±.00 125.1±1.50 
2 80 0.183±0.01 20 0.079±0.00 172.4±0.75 
3 120 0.203±0.01 40 0.179±0.00 199.8±0.99 
4 160 0.361±0.2  Average 165.76±1.08 
5 200 0.451±0.1  
*mean of three readings ± SEM 
 
Fig .17 :calibration curve for tannic acid 
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The linear regression equation was found to be y = 0.0224x+ 0.0038 while the 
correlation was found to be 0.9974. The amount of flavonoid content present in the ethanolic 
extract of Cordia obliqua in terms of mg quercetin equivalent/g of extract was found to 
be165.7±1.08mg/g of extract by using the above linear regression equation 
 
SECTION -D 
CHROMATOGRAPHY 
Chromatography is the separation of the compounds of mixtures by their continuous 
distribution between two phases. The mixture is dissolved in a fluid called the mobile phase, 
which carries it through a structure holding another material called the stationary phase. The 
various constituents of the mixture travel at different speeds, causing them to separate. The 
separation is based on differential partitioning between the mobile phase and stationary phase 
(99). 
The various types of chromatography include paper chromatography (PC), thin layer 
chromatography (TLC), column chromatography (CC), gas chromatography (GC), high 
performance liquid chromatography (HPLC) and high performance thin layer 
chromatography (HPTLC). 
Thin Layer Chromatography (100,101) 
Thin layer chromatography (TLC) is a chromatographic technique used for the 
separation of mixtures. The principle involved is adsorption. The solute competes with the 
solvent for the surface sites on the adsorption. Depending on the distribution coefficients, the 
compounds are distributed on the surface of the adsorbant.The compounds, which is readily 
soluble but not strongly adsorbed, moves up along with the solvent and that compounds not 
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so soluble but more strongly adsorbed move up less readily leading to the separation of 
compounds. 
Preparation of TLC Plates 
 The adsorbent (silica gel G) slurry was prepared in water in the ratio of (1: 2). The 
glass plates (20cm x 5cm) were cleaned and laid in a row as a template, the suspension was 
poured into Stahl TLC spreader, which was adjusted to 0.25mm thickness and coated in a 
single passage of the spreader over them. These plates were air dried and activated in hot air 
oven at 105ºC for 30min and kept in a dessicator. The plates were used as the stationary 
phase or Pre-coated aluminum plates coated with silica gel G F254 (Merck) were also used for 
analysis.  
Sample application  
The sample was prepared by dissolving the ethanolic extract of Cordia obliqua in 
ethanol to get 5mg/ml. The sample was applied as a spot with the help of capillary tube.  
Development of the chromatogram 
The extracts were dissolved in ethanol and the spot was applied on the TLC plates 
using capillary tube. 
The plates were developed in the chromatographic tank containing the solvent 
systems.  Various solvent systems were tried for better results.  The TLC plates were allowed 
to develop upto 2/3rd of the plate length and dried.  The TLC plates were examined visually 
or under UV light. 
 Stationary phase - silicagel G 
 Mobile phase   - Ethylacetate:Benzene(2:8) 
- Chloroform: Ethylacetate(6:4) 
 Detecting agent        - Visual & UV light  
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The Rf value of the spots obtained were calculated by using the formula, 
Rf=
ୈ୧ୱ୲ୟ୬ୡୣ	୘୰ୟ୴ୣ୪୪ୣୢ	ୠ୷	ୗ୭୪୳୲ୣ	
ୈ୧ୱ୲ୟ୬ୡୣ	୘୰ୟ୴ୣ୪୪ୣୢ	ୠ୷	ୗ୭୪୴ୣ୬୲ 
 
Two spots showed fluorescence when viewed under UV light. The Rf value of 0.35, 
0.78 at 365nm for the ethanolic extract of Cordia obliqua leaves in Ethyl acetate: Benzene 
(2:8). The extract also showed 2fluorescent spots at Rf value of 0.52 and 0.98 when viewed 
under UV at 365nm after development in the mobile Chloroform:ethyl acetate(6:4). 
 
Table16: TLC of the Ethanolic extract of Cordia obliqua willd 
 
 
S. No Solvent system Detecting agent
No of 
spots 
Colour of spots Rfvalues 
1. Ethyl acetate: 
Benzene (2:8) 
Under UVlight 
at 365nm 
I Yellow colour 0.35 
II  Orange fluorescence 0.78 
2. Chlopoform: ethyl 
acetate (6:4) 
 
Under UVlight 
at 365nm 
I Yellow colour 0.52 
II Orange fluorescemce 0.98 
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SECTION -E 
HIGH PERFOMANCE THIN LAYER CHROMATOGRAPHY ANALYSIS OF 70% 
ETHANOLIC EXTRACT OF CORDIA OBLIQUA WILLD. LEAVES 
High performance thin layer chromatography (HPTLC)is a modern adaptation of TLC 
with improved versatility, separation efficacy and detection limits. HPTLC is useful for the 
identification of plants and their extracts because each plant species produces a distinct 
chromatogram, with unique marker compounds used for plant identification. 
This is a sophisticated advancement in thin layer chromatography. It has advantages 
like better resolution, faster development of spots and also easy detection and quantification 
of separated compounds.   
APPLICATION OF HPTLC 
1. For the detection and analysis of components in phytochemistry, medicinal chemistry 
and organic chemistry. 
2. Compounds which are very complex or those in very scarce quantities can be 
analyzed  (102). 
HIGH PERFOMANCE THIN LAYER CHROMATOGRAPHY (HPTLC) 
Instrument used : CAMAG make HPTLC. 
Software  : winCATS 1.4.3 
Sample Applicator : Linomat 5. 
Detection  : @520nm, @254nm & @366nm in Densitometry TLC Scanner 3                                 
Sample preparation : sample was dissolved in 1 ml ethanol 
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Stationary Phase : HPTLC plates silica gel 60 F 254. 
Mobile Phase  : Ethyl acetate: Toluene (2:8) 
Sample Solution : 2l sample is applied as 8mm band. 
PROCEDURE 
The samples (10µl) were applied as spot, about 6mm from the edge of the TLC plates. The 
plates were developed upto 120mm in the mobile phase. 
Table: 17: HPTLC profile of ethanolic extract of Cordia obliqua willd leaves 
S.No 
White light @ 254nm @ 366nm 
Rf 
value 
Area  
(AU) 
Rf 
value 
Area  
(AU) 
Rf 
value Area  (AU) 
1 0.10  174.9  0.10  1195.1  0.10  2425.5  
2 0.20  485.6  0.16  355.9  0.17  658.3  
3 0.44  602.3  0.20  834.8  0.22  2266.9  
4 0.48  1396.3  0.32  276.3  0.36  5366.4  
5   0.34  479.9  0.44  3785.8  
6   0.43  383.0  0.47  9496.0  
7   0.48  1084.3  0.57  1853.3  
8   0.58  447.8  0.69  1385.3  
9   0.61  1390.7  0.77  3641.1  
10   0.79  1695.7  0.82  1827.4  
11   0.82  1358.7  0.91  324.2  
12   0.91  4310.4    
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CHAPTER – VI 
PHARMACOLOGICAL SCREENING 
SECTION - A 
IN-VITRO ANTIOXIDANT ACTIVITY 
Antioxidants regarded as compounds which are able to delay, retard or prevent 
oxidation process(103). Reactive oxygen species (ROS) are generated in the normal 
metabolism of living organisms and besides of their useful role in signal transduction, they 
are also involved in the dispersion of several degenerative disease like malignant 
tumors,rheumatic joint inflammation, cataracts, Parkinson’s and Alzheimer’s disease, 
hypertension, diabetes, oxidative stress, tissue damage and atherosclerosis.(104). The role of 
medicinal plants in disease prevention or control has been attributed to the antioxidant 
properties of their constituents such as vitamins, terpenoids, phenolic acids, stilbenes, tannins, 
flavonoids,quinones, coumarians, alkaloids, which are rich in antioxidant activity(105).  The 
ingestion of natural antioxidants has been associated with reduced risk of cancer, 
cardiovascular disease, diabetes, and other diseases associated with ageing (106,107). 
Method 1: Free radical Scavenging activity using diphenylpicrylhydrazyl (DPPH) free 
radical 
The free radical scavenging activity of the extracts is evaluated by assessing their 
ability to reduce the colour of DPPH in ethanol according to Brand Williams (108). DPPH is a 
stable, free radical and this method is an easy, rapid and sensitive way to survey the 
antioxidant activity of specific compound or plant extracts. (109) 
Principle 
This is a simple method that has been developed to determine the antioxidant activity 
of plants which utilizes the stable 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. The odd 
electron in the DPPH free radical gives a strong absorption maximum at 517nm and is purple 
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in color.  The color turns from purple to yellow as the molar absorptivity of the DPPH radical 
at 517nm reduces from 9660 to 1640 when the odd electron of DPPH radical becomes paired 
with hydrogen from a free radical scavenging antioxidant to form the reduced DPPH-H.  The 
resulting decolorization is stoichiometric with respect to number of electrons captured (110). 
   DPPH. + AH   DPPH – H + A. 
Instrument 
Shimadzu UV Visible spectrometer, Model 1800 
Reagents 
0.1mM Diphenyl Picryl Hydrazyl ( DPPH) in ethanol. 
Procedure(109,110,) 
A stock solution of DPPH was prepared in ethanol(4mg/100ml). 1mg/1ml 
concentration of ethanolic extract of Cordia obliqua leaves was prepared. To 1 ml of the 
various concentrations of test samples(0.5ml,0.6ml,0.7ml and 0.8ml of extract in ethanol), 
4ml of DPPH solution was added. Control was prepared without sample in an identical 
manner. Ethanol was used as blank. The reaction was allowed to be complete in the dark for 
about 30min. Then the absorbance was measured at 517nm. Vitamin C was used as standard. 
The percentage scavenging was calculated using the formula [(Control-Test)/Control] x 100. 
A graph was constructed by plotting concentration versus percentage inhibition. The 
concentration of the sample required for 50% reduction in absorbance (IC50) was calculated 
using linear regression analysis.  A triplicate reading was taken and the average was 
calculated.  The results obtained were presented in Table- 18and Fig. 22. 
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Method I: Free radical Scavenging activity using diphenylpicrylhydrazyl (DPPH) free 
radical 
Table 18: Percentage inhibition of ethanolic extract of 
Cordia obliqua leaves and standard ascorbic acid against DPPH at 517nm 
S. No. Conc. in μg/mL Percentage inhibition 
by ascorbic acid 
Percentage 
inhibition by Extract 
1 50 65.72±3.18 56.2±1.34 
2 60 73.8±2.85 65.16±1.30 
3 70 84.49±1.55 72.85±1.50 
4 80 95.39±1.28 80.16±1.44 
 IC50 40.42μg/ml 47.23μg/ml 
*mean of three readings ± SEM 
 
Fig. 22 – Free radical scavenging activity of 
ethanolic extract of Cordia obliqua leaves ( EECO) by DPPH method at 517nm 
 
 
 
 
 
 
 
From the results, obtained it has been observed that, the ethanolic extract of Cordia  
obliqua showed a percentage inhibition of 80.16±1.44 while ascorbic acid showed a 
percentage inhibition of 95.39± 1.28 at a concentration of 80µg/ml.  The IC50 value 
calculated using the linear regression analysis was found to be 47.23 and 40.42ssμg/ml for 
the ethanolic extract and ascorbic acid respectively. This study showed that the extract 
possess a significant free radical scavenging capacity. 
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Method 2: Ferric Reducing Antioxidant Power (FRAP) Assay (111,112) 
Total antioxidant activity is measured by FRAP assay of Benzie et al., (1999) (111). 
The ferric reducing antioxidant power assay measures the potential of antioxidants to reduce 
the Fe3+ and 2,4,6 tripyridyl-s-triazyne (TPTZ) complex present in stoichiometric excess to 
the blue coloured Fe2+ complex which increases the absorption at 593nm. 
Principle  
At low pH, reduction of ferric tripyridyltriazine (Fe III TPTZ) complex to ferrous 
form(which has an intense blue colour) can be monitored by measuring the change 
inabsorption at 593nm. The reaction is non-specific, in that any half reaction that haslower 
redox potential, under reaction conditions, than that of ferric ferrous half reaction, will drive 
the ferric to ferrous (Fe III to Fe II) ion formation. The change in absorbance istherefore, 
directly related to the combined reducing power of the electron donating antioxidants present 
in the reaction mixture. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
FRAP Reagent  
a) Acetate buffer 30mM pH 3.6: Weigh 3.1g sodium acetate trihydrate and add 16 
ml of glacial acetic acid and make the volume to 1 L with distilled water. 
  b)  TPTZ (2, 4, 6-tripyridyl-s- triazine) (M.Wt. 312.34) 10mM in 40mM HCl 
c)  FeCl3. 6H2O (M.Wt. 270.30) 20mM 
The FRAP reagent was prepared freshly by mixing a,b& c in the ratio of 10:1:1 at the 
time of use.  
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Procedure  
 50µl, 100µl, 150µl, 200µl and 250µl of 2mg/ml concentration of ethanolic extract of 
Cordia obliqua were taken and mixed with 3ml of working FRAP reagent and absorbance 
was measured at 0min at 593nm. Thereafter samples were placed at 37ºC in water bath and 
absorption was again measured after 4min. Ascorbic acid was used as standard. The FRAP 
value of the sample was calculated using this equation:[Change in absorbance of sample from 
0-4min/ change in absorbance of standard from 0-4min] * Frap value of standard was also 
observed.The results obtained for the FRAP assay were presented in the Table. 19 and Fig. 
23. 
Table:19: Ferric reducing antioxidant assay of ascorbic acid 
andethanolic extract of Cordia obliqua leaves 
 
S. 
No 
Conc. in 
µg/ml 
Absorbance 
of ascorbic 
acid 
Absorbance of 
ethanolic extract 
1 50 0.817±0.06 0.625±0.02 
2 100 1.663±0.05 0.920±0.02 
3 150 2.504±0.05 1.424±0.01 
4 200 3.206±0.03 1.877±0.15 
5 250 4.075±0.06 2.374±0.231 
    *Mean of three readings ± SEM 
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Fig. 23: Ferric reducing anti-oxidant assay of 
ethanolic extract of Cordia oblique leaves 
 
                 
 
From the table, it can be seen that the ethanolic extract of Cordia  obliqua leaves 
showed an absorbance of 2.374 ±0.231 for a concentration of 250µg/mlwhile ascorbic acid 
showed an absorbance of 4.075 ±0.06 at a concentration of 250µg/ml.  The extract shows a 
dose dependent reducing ability. The graphical representations of the reducing power activity 
of the ethanolic extract of Cordia obliqua and ascorbic acid were presented in Fig 23.ASIAN 
J. EXP. BIOL. SCI. VOL 2(1) 2011: 58-62ASIAN J. EXP. BIOL. SCI. V 
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Method 3:Total antioxidant activity by Phosphomolybdenum  assay(113,114) 
Principle 
Total antioxidant capacity was measured by spectrophotometric method of Prietoet 
al(1999) [113]. Phosphomolybdenum method assay is based on the reduction of Mo (VI) to Mo 
(V) by the sample analyte and the subsequent formation of green phosphate Mo (V) complex 
at acidic pH and the absorbance was measured at 695nm. This method is used to determine 
the total antioxidant activity of samples. 
Mo6+         →        Mo5+ 
Reagents 
0.6M sulphuric acid 
28mM sodium phosphate 
4mM   ammonium molybdate 
Instruments 
Shimadzu UV Visible spectrophotometer, Model 1800 
Procedure 
An aliquot of 0.3ml of different concentrations of sample solutions was combined 
with 2.7ml of the reagent solution (H2SO4, sodium phosphate and ammonium molybdate). In 
case of blank, 0.3ml of ethanol was used in place of sample. The tubes were incubated for 
95°C for 90min. After the mixture was cooled to room temperature, the absorbance was 
measured at 695nm against blank. The standard Ascorbic acid was treated in a similar 
manner. The total antioxidant activity is expressed as the number of equivalents of ascorbic 
acid [114]. 
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Table 20: Percentage inhibition of ascorbic acid and ethanolic 
extract of Cordia obliqua by Phosphomolybdenum method at 695nm 
S. No. 
Conc. in 
μg/ml 
Percentage 
inhibition by 
standard ascorbic 
acid 
Percentage 
inhibition by 
extract 
1 33.33 0.373±0.03 0.046± 0.01 
2 50 0.561 ± 0.01 0.076± 0.01 
3 66.66 0.747± 0.00 0.100 ± 0.00 
4 83.33 0.935 ± 0.01 0.177 ± 0.01 
5 100 1.1±1.00 0.261±0.01 
                                                        *mean of three readings ± SEM 
 
Fig 24 : Percentage inhibition of ascorbic acid and ethanolic extract of Cordia 
 obliqua byPhosphomolybdenum method at 695nm 
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From the table, it can be seen that the ethanolic extract of C. obliqua showed an 
absorbance of 0.261± 0.01 for a concentration of 100µg/mlwhile ascorbic acid showed an 
absorbance of 1.1±0.02 at a concentration of 100µg/ml.  The extract shows a dose dependent 
reducing ability. The graphical representations of the reducing power activity of the ethanolic 
extract of Cordia obliqua and ascorbic acid are presented in Fig 24. 
Method 4: Nitric oxide scavenging activity assay (115,116) 
Principle   
Nitric oxide scavenging activity was determined according to the method reported by 
Green et al., (1982) (115). The procedure is based on the principle that sodium nitroprusside in 
aqueous solution at physiological pH spontaneously generates nitric oxide which interacts 
with oxygen to produce nitrite ions that can be estimated using Griess reagent. Scavengers of 
nitric oxide compete with oxygen, leading to reduced production of nitrite ions. The nitrite 
ions produced diazotizes sulphanilamide and then the diazonium salt reacts with N,N 
naphthyl ethylene diaminedihydrochloride to give a pink colourchromophore which has a 
maximum absorption at 546nm.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
10mM sodium nitroprusside 
Phosphate buffered saline pH 7.4 
2% sulphanilamide in ortho phosphoric acid 
0.1% naphthyl ethylene diaminedihydrochloride 
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Procedure 
To 1ml of freshly prepared solution of sodium nitroprusside, 2.5ml phosphate 
buffered saline pH 7.4 was added and mixed with 1ml of extracts at various concentrations 
(0.2,0.4,0.6,0.8 and 1ml of 1mg/ml), then the mixture was incubated at 25oC for 30min. From 
the incubated mixture 1.5ml was taken. To this, 1ml of sulphanilamide in phosphoric acid 
and 0.5ml of naphthyl ethylene diaminedihydrochloride were added and the absorbance was 
measured at 546nm using reagent as blank. A control without the extract was also prepared 
and  subjected to the above procedure. Ascorbic acid was used as a standard.  
The percentage inhibition of nitric oxide radical generated was calculated using the 
following formula: % inhibition = [(Control-Test)/Control] x 100. 
A graph was constructed using concentration versus percentage inhibition and the 
linear regression equation calculated. The IC50 was calculated using linear regression 
analysis. The results obtained for the nitric oxide scavenging activity assay were presented in 
Table 21 and Fig 25. 
 
Table 21: Percentage inhibition of ascorbic acid and ethanolic 
extract of C.obliqua against nitric oxide at 546nm 
S. No. Conc. in 
μg/mL 
Percentage inhibition by 
standard ascorbic acid 
Percentage inhibition 
by extract 
1 66.33 39.73±0.21 31.07 ± 1.38 
2 133.33 79.87± 0.44 69.27 ± 1.03 
3 200 119.8 ± 0.66 79.13 ± 1.10 
4 266.66 159.74 ± 0.80 119.05 ± 2.81 
5 333.33 199.67±1.10 138.19±1.18 
 IC50 83.47μg/ml 111.47μg/ml 
*mean of three readings ± SEM 
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Fig 25: Nitric oxide scavenging activity of ascorbic and ethanolic 
Extract of C.obliqua 
             
From the table, it can been seen that the ethanolic extract of Cordia obliqua leaves 
showed a percentage inhibition of 138.19 ± 1.18 while ascorbic acid showed  a percentage 
inhibition of 199.67 ± 1.10 at a concentration of 333.33µg/mL.  The IC50 value calculated 
using the linear regression analysis was found to be 111.47and 83.47μg/mL for ethanolic 
extract and ascorbic acid respectively.  
 
Method 5 : Reducing power assay (117,118) 
Principle 
Reducing power assay is a spectrophotometric method and is based on the principle 
that increases in absorbance of the reaction mixture indicates the increases in the reducing 
power of the sample.Antioxidant activity may be due to a variety of mechanism viz.,the 
prevention of chain initiation , the binding of transition metal ion catalysts, decomposition of 
peroxides,thereductive capacity and free radical scavenging.  The assay is based on the 
reduction of ferric in potassium ferricyanide to ferrous to form potassium ferrocyanide by the 
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sample and the subsequent formation of Prussian blue colour with ferric chloride. The 
absorbance of the blue complex is measured at 700nm.  
Potassium ferricyanide+  Ferric chloride   
                                     Antioxidant 
Potassium ferrocyanide + Ferrous chloride 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Materials required 
70% Ethanolic extract of leaves of Cordia obliqua 
Ascorbic acid 
1% w/v Potassium ferricyanide 
10% w/v Trichloroacetic acid   
0.2M, Phosphate buffer (pH 6.6) 
0.1% w/v Ferric chloride 
Procedure 
The reducing power ability of plant extracts was screened by assessing the ability of 
the test extract to reduce FeCl3solution as mentioned by Oyaizu etal (1986) (118). 0.1 to 0.5 ml 
of plant extract solution (1mg/ml) was mixed with 0.75ml phosphate buffer and 0.75ml of 1%   
potassium ferricyanide [K3Fe(CN6)] and incubated at 50oC for 20min.0.75ml of 
1%trichloroacetic acid was added to the mixture ,allowed to stand for 10min. The whole 
mixture was then centrifuged at 3000rpm for 10min. Finally 1.5ml of the supernatant was 
removed and mixed with 1.5ml of distilled water and 0.1ml of 0.1%ferric chloride solution 
and the absorbance measured at 700nm in UV-Visible Spectrophotometer.  Ascorbic acid 
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was used as standard and phosphate buffer used as blank solution. The results obtained for 
the free radical scavenging activity against reducing power assay were presented in Table 22.  
Table 22: Reducing power assay of ascorbic acid and ethanolic 
extract of Cordia obliqua leaves 
S. No. Conc. in 
μg/ml 
Percentage inhibition by 
standard ascorbic acid 
Percentage inhibition 
by extract 
1 100 0.165±0.007 0.062 ± 0.001 
2 200 0.368± 0.014 0.17 ± 0.001 
3 300 0.565 ± 0.019 0.373 ± 0.001 
4 400 0.776 ± 0.003 0.581 ± 0.002 
5 500 1.097±1.017 0.690±0.002 
*mean of three readings ± SEM 
 
Fig 26: Reducing power assay of ascorbic acid and ethanolic 
Extract of Cordia obliqua 
 
 
 
 
From the table, it can been seen that the ethanolic extract of Cordia obliqua leaves 
showed a percentage inhibition of 0.690 ± 0.002 while ascorbic acid showed  a percentage 
inhibition of 1.097 ± 1.01 at a concentration of 500µg/ml. 
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SECTION - B 
ANTI-INFLAMMATORY ACTIVITY OF ETHANOLIC EXTRACT OF CORDIA 
OBLIQUA AGAINST CARRAGEENAN INDUCED PAW EDEMA IN RATS 
Inflammation is a complex biological response of vascular tissue to harmful stimuli 
caused by injury, infection, environmental agents, malignancy and cellular changes. It is a 
protective attempt by the body to remove the injurious stimuli as well as to initiate the 
healing process for the tissue (119). 
 The inflammation response is a complex process that includes activation of white 
blood cells, the release of immune system chemicals such as complements and cytokines and 
the production and release of inflammation mediators and prostaglandins (120). 
 The complete process of anti - inflammation generally consists of three phases  
1. Dilatation and increased permeability of small blood vessels resulting in oedema 
and swelling. 
2. Emigration of leucocytes from venules and capillaries, cellular filtration and a 
general mopping up reaction and 
3. Proliferation of fibroblast and synthesis of new connective tissue to repair the 
injury(121).  
 Similarly, the paw oedema induced by histamine, 5- HT, bradykinin, dextran, 
hyaluronidase and prostaglandins E have been used for studying the antagonism to those 
mediators. 
The anti-inflammatory activities of ethanolic extract of Cordia obliqua at a dose of 
200 mg/kg and 400mg/kg body weight were evaluated using carrageenan-induced paw 
oedema method. The inflammation was readily produced in the form of oedema with the help 
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of irritant such as carrageenan. Carrageenan is a sulphated polysaccharide obtained from sea 
weed (Rhodophyceae) and when injected cause the release of prostaglandins, by the way it 
produces inflammation and edema (121). 
REQUIREMENTS: 
Animal                                 : Albino rat (180-200 g) 
Drugs and chemicals            : Carrageenan (1%w/v), Diclofenac sodium (standard), 
                                                        : Ethanolic Extract of Cordia obliqua. Digital plethysmometer                         
METHOD: 
The animals were divided into 4 groups each having six animals.  
 PROTOCOL 
Group – 1: Treated as normal control which received 10ml/kg of normal saline through 
orally. 
Group – 2: Treated as Standard control which received 10mg/kg of diclofenac sodium 
through Intraperitonealy. 
Group – 3: Treated as treatment control which received 200mg/kg EECO dissolved in 2ml 
sterile water and administered orally. 
Group - 4: Treated as treatment control which received 400mg/kg EECO dissolved in 2ml 
sterile water and administered through orally. 
A freshly prepared suspension of carrageenan (1% w/v , 0.1 ml) was injected to the 
planter region of left hind paw of each rat. One group was kept as control and the animals of 
the other groups were pretreated with the synthetic compounds given through 
intraperitoneally 30 min before the carrageenan treatment. The paw volumes of the treatment 
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controls, standard and control groups were measured at 60,240,360 minutes of carrageenan 
treatment with the help of Digital plethysmometer (Ugobasile, Italy). Mean increase in paw 
volume was measured and the percentage of inhibition was calculated (122). 
% Anti-inflammatory activity = (Vc-Vt / Vc) x 100 
Where, Vt- mean increase in paw volume in rats treated with test compounds, 
Vc- mean increase in paw volume in control group of rats. 
STATISTICS: 
Data are expressed as mean ± SEM; data analyzed by one way ANOVA followed by 
Newman’s keul’s multiple range tests to determine the significance of the difference between 
the control group and rats treated with the test compounds. 
  *   Values were considered significant at P< 0.01. 
TABLE No.23:Anti-inflammatory activity of EECO by induced paw edema method 
Treatment Dose (mg/kg) 
Paw volume(ml) as 
measured by mercury 
displacement at 6 
hour 
Percentage inhibition 
of paw edema 
Group I Normal 
saline 
10ml/kg orally 5.68±0.95 - 
Group II Std 
10mg/kg,i.p. 
Diclofenac sodium 
1.85±0.35 67.42%*a 
Group III 200mg/kg  EECO 2.15±0.55 62.14%*a 
Group IV 400mg/kg EECO.  1.90±0.66 66.54%*a 
* Data are expressed as Mean ± S.E.M. 
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*Data were analyzed by one way ANOVA followed by Newman’s keul’s multiple range 
tests, to determine the significance of the difference between the control group and rats 
treated with the test compounds. 
*a   Values were significantly different from normal control at P< 0.01. 
Anti- inflammatory activity 
Ethanolic extract of Cordia obliqua at a dose of 200 and 400mg/kg were tested for 
their Anti- inflammatory activity by using carrageenan Induced rat paw edema method and 
the results were tabulated in table no 1.  The results reveals that both extracts at a dose of 200 
and 400mg/kg doses possesses significant Anti- inflammatory activity when compared to 
control group  p<0.01. 
SECTION - C 
ANTIBACTERIAL ACTIVITY OF ETHANOLIC EXTRACT OF CORDIA OBLIQUA 
WILLD. LEAVES 
 Antimicrobial activity of plants can be detected by observing the growth response of 
various microorganisms to those plant extracts, which are placed in contact with them (123).
  
 In order to detect antimicrobial activity in plant extracts, three conditions must be 
fulfilled. 
 First, the plant extract must be brought into contact with the cell wall of the 
microorganisms that have been selected for the test. Second, conditions must be adjusted so 
that the microorganisms are able to grow when no antimicrobial agents are present. Third, 
there must be some means of judging the amount of growth if any made by the test organism 
during the period of time choosen for the test. The currently available methods for 
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antimicrobial activity fall into three groups viz. diffusion, dilution and bioautographic 
methods (124). 
The ethanolic extract of Cordia obliqua was screened for antibacterial activity on four 
bacterial strains and the zone of inhibition was determined. 
Preparation of extract  
The ethanolic extract of Cordia obliqua was dissolved in DMSO solution and to produce a 
stock solution of 2mg/ml. A quantity of 200, 400 and 600 mcg were impregnated on the plain 
sterile disc and dried. 
Preparation of MH agar medium 
Muller Hinton agar (MHmedia) was used for culture of bacterial strains. It consists of 
Beef 2g, casein acid hydrolysate 17.5g, starch 1.5g and agar 17g (pH 7.4 ± 0.2). MH agar 
(38g) was weighed and dissolved in 1000ml of distilled water and adjusted to pH 7.3 ± 0.2, 
sterilized by autoclaving at 121oC for 15min at 15psi pressure and was used for sensitivity 
tests. This medium was used for screening Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus (125). 
Preparation of Blood agar medium  
Blood agar medium (BAM) contains mammalian blood usually at a concentration of 
5–10%. Blood agar medium are enriched, differential media used to isolate fussy organisms 
and detect hemolytic activity. β-hemolytic activity will show lysis and complete digestion of 
red blood cell contents surrounding colony.  
The media contains nutrient substrate (heart extract and peptones) 20.0; sodium 
chloride 5.0: agar-agar 15.0. 40g of the above media was suspended in 1000ml of distilled 
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water and autoclaved for 15min at 121°C and cooled to 45-50°C. The prepared medium was 
clear and yellowish-brown and then 5-8% defibrinated blood was added (126).  
The blood agar medium was used for the antibacterial activity against the bacterial 
strains namely Streptococcus pyogens. 
Preparation of bacterial cultures  
 The various bacterial strains like E. coli, P.aeruginosa, etc. were utilized for 
screening antibacterial activity. A few colonies of the bacterial strains picked from the agar 
slopes and were inoculated into 4ml peptone water in a test tube. They were incubated for 
24h to form suspensions. The suspension was diluted with saline if necessary. 
  The visual density equivalent to standard prepared by adding 0.5ml of 1% barium 
chloride to 99.5ml of 1%sulphuric acid. These suspensions were then used for seeding (127).  
Disc diffusion technique 
The MH media was poured aseptically into sterilized petridishes and the petridishes 
were swirled to settle the agar and allowed to cool. The bacterial strains were seeded on the 
MH agar media by streaking the plate with a sterile swab containing the strain. The plain 
sterile discs were impregnated with various volumes of the extract, volatile oil and DMSO 
(negative control) and dried. Imipenum (30µg/disc) was used as standard. The discs were 
then placed on the plate with the help of sterile needle and the plates were incubated at 37°C 
for 24h (128). 
Similarly the blood agar medium was used for antibacterial activity against the 
Streptococcus species and the above procedure was adopted. 
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The results were read and the zone of inhibition was then measured and  were 
presented in Tables 24The photographic representations of the antibacterial activity were 
presented in Fig 23-26& 27. 
 
Table No.31:  Antibacterial activity of ethanolic extract of Cordia obliqua  willd leaves. 
 
S.No Microorganism 
Imipenum Ethanolic extract of cordia obliqua 
Concentration 
(µg) 
Zone of 
inhibition(mm) 
Concentration 
(µg) 
Zone of 
inhibition(mm) 
01 Escherichia coli 
30 
26 
200 
400 
600 
- 
12 
18 
02 Pseudomonas aeruginosa 25 
200 
400 
600 
- 
10 
18 
03 Staphylococcus aureus 24 
200 
400 
600 
- 
12 
18 
04 Streptococcus pyogens 26 
200 
400 
600 
- 
10 
18 
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Fig.27 : Zone of inhibition of EECO against various organisms 
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CHAPTER – VII 
RESULTS AND DISCUSSION 
 
This dissertation deals with the Pharmacognostical, Phytochemical and 
Pharmacological studies of leaves of Cordia obliqua willd., Family -Boraginaceae in an 
attempt to rationalize its use as a drug of therapeutic importance. 
CHAPTER- I 
This chapter gives relevant information about the traditional system of medicine, 
herbal medicines and the role of herbal medicines in traditional healing.Natural products for 
modern medicines and safety in herbal drugs were discussed in this chapter. Significance of 
medicinal plants to human beingswere also discussed in this chapter.  Cause of inflammation, 
comparison between acute and chronic inflammation, chemical mediators of the 
inflammatory response and anti - inflammatory herbs and species were discussed in 
thechapter. Antibacterial activities,classification of various types of infections such as 
bacterial infection, mechanism of action of antibacterial agents were also discussed in this 
chapter. 
CHAPTER- II 
In this chapter, literature survey pertaining to the pharmacognostic, phytochemical, 
pharmacological studies and ethnomedical information of Cordia obliqua willd and its related 
species has dealt. 
CHAPTER-III 
Aim and scope of the study have been discussed in this chapter. Ethnomedical uses 
were also discussed. Pharmacognostical, Phytochemical studies which were planned to carry 
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out for this plant were discussed. Pharmacological studies which were planned to carry out 
for this plant were also discussed in this chapter. 
CHAPTER-IV 
In this chapter an attempt has been made to fix certain Pharmacognostic standards for 
the leaves of Cordia obliqua willd which includes the macroscopical, microscopical 
characters and physical parameters. 
SECTION- A 
Botanical name, synonyms, common name, vernacular names, taxonomic 
classification, geographical distribution(Habitat), description of tree, leaves, flowers, fruits 
and  bark  of the plant were described in detail, to identify the plant with the support of 
photographs as an establishment of authenticity.( Fig -5-8) 
Salient features of the macroscopy of the leaves were observed, such as the leaves are 
alternate, ovate, 10.1 cm long, 5.7 cm broad, entire to slightly dentate margin with pinnately - 
reticulate venation. 
SECTION- B 
It deals with the microscopical studies of the leaves to ascertain the arrangement of 
tissues. (Fig-9-14) 
 The leaf is dorsiventral, xeromorphic and hypostomatic. 
 The midrib is thick and wide and Plano - convex in sectional view; the adaxial side is 
flat and the abaxial part is semicircular. 
 The structure of the vascular system is complex. It consists of abaxial wide, shallow 
bowl shaped vascular strand and two smaller adaxial vascular strands. 
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 The abaxial vascular strand consists of several solitary diffusely distributed xylem 
elements and thick walled, lignified fibres. 
 The adaxial vascular strands are collateral having a few rows of xylem elements and 
phloem on the outer part of the xylem. 
 The adaxial epidermis is fairly thick walled; the cells are cylindrical and have 
prominent cuticle. 
 The abaxial epidermis has smaller, thin walled cells.  
 The epidermis is stomatiferous. 
 The palisade cells are thin, elongated, compact and chlorophyllous. 
 Calcium carbonate crystals are located in specially modified epidermal cells of the 
leaf.  
 The epidermal cells are lightly dilated into circular (spherical) cells called lithocysts; 
within the lithocysts occur cystolith with a short stalk attached on the epidermal cell 
wall.  
 Calcium oxalate crystals are large, granular bodies located in the ground parenchyma 
of the midrib and mesophyll cells. 
  The vein- islets are narrow, squarish or polyhedral in outline.  
 The vein boundary is thick. The vein -termination are short and thick. They are 
simple, forked once or twice. 
 The trichome is nonglandular type. 
 Stomata occur on the abaxial epidermis only. 
 The stomata are actinocytic having three or four radiating subsidiary cells. 
 The adaxial epidermis is apostomatic.  
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SECTION – C 
It deals with the quantitative microscopy such as stomatal number, stomatal index, 
vein - islet number, vein termination number which were determined and tabulated as 
follows. 
Contents 
Leaves 
Min Ave Max 
Stomatal Number 53 62.5 79 
Stomatal Index 45.73 48.41 58.94 
Vein islet Number 9 16.9 27 
Vein termination number 19 28.9 39 
 
SECTION - D 
The following physical parameters like ash values, extractive values, loss on drying, 
foaming index, swelling index were determined and tabulated. 
 
ASH VALUE AND LOSS ON DRYING 
Contents Total ash Acid insoluble ash 
Water 
soluble ash Sulphated ash 
Loss on 
drying 
Minimum 8.86 0.84 0.94 0.90 9.32 
Average 10.64 0.88 0.94 0.92 11.23
Maximum 12 0.90 0.90 0.94 10.10
Foaming index <100 
Swelling index 3.66±0.81 
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EXTRACTIVE VALUE BY COLD MACERATION 
S.No 
Solvents Used (Increasing order 
of polarity) 
Extractive 
Value% w/w 
1 Petroleum ether 16.79 
2 Ethyl acetate 1.19 
3 Chloroform 2.95 
4 Ethanol 2.67 
5 Acetone 1.59 
6 Water 18.22 
. 
SECTION - E 
i). Fluorescence analysis of extract of Cordia obliqua willd 
Extracts Colour in Day 
light  
Colour under 
UV Lamp 
254nm 
Colour under 
UV Lamp 
365nm 
Colour in visible 
Acetone Dark 
green 
Dark 
green  
Orange Dark 
green 
Ethanol Green Green Orange Light 
green 
Ethyl acetate Dark 
green 
Green Orange Light 
green 
Chloroform Green Green Orange Puff 
colour 
Petroleum ether Brown Light 
green 
Brown Brown 
Water Brown Green Honey 
colour 
Brown 
 
ii). Powder analysis 
The following anatomical characters were observed in the powder microscopy of 
leaves reveals the presence of  
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 Stomata - Actinocytic stomata 
 Trichome – Non glandular type, bulbous basal part 
 Calcium oxalate crystels 
 Starch grains 
 Lignified sclerenchyma 
 Paranchyma 
CHAPTER- VI 
PHYTOCHEMICAL STUDIES 
SECTION - A 
This section dealt with organoleptic evaluation of the leaves of Cordia obliqua willd. 
 
SECTION - B 
Preliminary Phytochemical screening 
This section was dealt with the phytochemical studies of the leaves of Cordia obliqua. 
This study was carried out for both powdered crude drug and various extract of Cordia 
obliqua. It reveals the presence of Carbohydrates, alkaloids, aminoacids, proteins, sterols, 
saponins, tannins, flavonoids and mucilage. 
Constituents Present  Constituents Absent 
Carbohydrates, amino acids, proteins, 
saponins, sterols, alkaloids, flavonoids, 
tannins, mucilage. 
Glycosides, gums, volatile oils. 
 
                                                                                                 Result and Discussion 
 
Department of Pharmacognosy,  MMC Page 96 
Preliminary phytochemical screening was carried out with various extracts (such as 
ethanol, aqueous, petroleum ether, methanol) of the leaf of this plant and the results were 
tabulated. (Table. 11 and 12) 
SECTION –C 
Determination of phenolic content 
  The total phenolic content for the ethanolic extract of Cordia obliqua leaves was 
found and shown in Table13.  The amount of phenolic content present in the extract in terms 
of mg GAE/g of extract was found to be 59.47 ±1.02 by using the linear regression equation. 
SECTION – D 
Determination of flavonoid content 
  The Total flavonoid content for the ethanolic extract of Cordia obliqua leaves was 
found and shown in Table14.  The amount of flavonoid content present in the ethanolic 
extract of Cordia obliqua leaves in terms of mg quercetin equivalent/g of extract was found 
to be 153.94 ± 1.20 mg/g, by using the linear regression equation. 
SECTION – E 
Determination of tannin content 
The total tannin content for the ethanolic extract of Cordia obliqua leaves was found 
and shown in Table 15. The amount of tannin content present in the ethanolic extract of 
Cordia obliqua leaves in terms of mg tannic acid equivalent/g of extract was found to 
be165.7±1.08mg/g, by using the linear regression equation. 
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SECTION – F 
TLC studies  
Thin layer chromatography studies were carried out for the ethanolic extract of 
Cordia  obliqua leaves using ethyl acetate: benzene and Chloroform: Ethyl acetate as mobile 
phase and the reports were presented in the (Table.16). 
 
   TLC STUDIES OF ETHANOLIC EXTRACT OF CORDIA OBLIQUAWILLD. 
S.NO DETECTING AGENT NO OFSPOTS Rf VALUE COLOUR 
1. 
Under UV light at 365 
nm 
I 0.35 Yellow colour 
II 0.78 
Orange 
fluorescences 
2. 
Under UV light at 
365nm 
I 0.52 Yellow colour 
II 0.98 
Orange 
fluorescences 
 
The TLC of EECO leaves when viewed under UV showed two spots at Rf value of 
0.35 & 0.78 at 365nm using (Ethyl acetate: Benzene) as mobile phase and two spots at the Rf 
value of 0.52 and 0,98 at 365nm using (Chloroform: Methanol) as mobile phase. 
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SECTION – G 
High performance thin layer chromatography 
An attempt has been made to develop the HPTLC chromatogram for the ethanolic 
extract of the leaves of Cordia obliqua, using the mobile phase (Ethyl acetate: Toluene). The 
HPTLC chromatogram of ethanolic leaf extract showed twelve peaks  at 254 nm and the Rf 
values were found to be 0.10, 0.16, 0.20, 0.32, 0.34, 0.43, 0.48, 0.58, 0.61, 0.79, 0.82, 0.91 
and eleven peaks  at 366nm and the Rf values were found to be 0.10, 0.16, 0.22, 0.32, 0.34, 
0.43, 0.48, 0.58, 0.61, 0.79, 0.82, 0.91. (Table.17) 
CHAPTER – VII 
SECTION – A 
Anti-oxidant activity 
This part of the study dealt with the pharmacological in- vitro screening of anti-
oxidant activity of Cordia  obliqua willd., leaves by the following five methods. 
PART - 1 
DPPH METHOD 
 From the results obtained, it has been observed that the ethanolic extract of Cordia 
obliqua leaves showed a percentage inhibition of 80.16±1.44,while ascorbic acid showed a 
percentage inhibition of95.39± 1.28 at a concentration of 80µg/ml.  The IC50 value, 
calculated by using the linear regression analysis was found to be 47.23 and 40.42μg/ml for 
the ethanolic extract and ascorbic acid respectively.  The extract possessed a good radical 
scavenging activity (Table. 18)  and Fig 22.  
PART – 2 
FREE RADIAL SCAVENGING ACTIVITY 
  From the table, it can be seen that the ethanolic extract of Cordia obliqua leaves 
showed an absorbance of 2.374 ±0.231 for a concentration of 250µg/ml, while ascorbic acid 
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showed an absorbance of 4.075 ±0.06 at a concentration of 250µg/ml.  The extract shows a 
dose dependent reducing ability. The graphical representations of the reducing power activity 
of the ethanolic extract of Cordia  obliqua and ascorbic acid were presented in (Table. 19) 
Fig 23 
PART – 3 
PHOSPHOMOLYBDENUM METHOD 
From the table, it can be seen that the ethanolic extract of Cordia obliqua showed an 
absorbance of 0.261± 0.01 for a concentration of 100µg/ml, while ascorbic acid showed an 
absorbance of 1.1±0.02 at a concentration of 100µg/ml.  The extract shows a dose dependent 
reducing ability. The graphical representations of the reducing power activity of the ethanolic 
extract of Cordia obliqua leaves and ascorbic acid were presented in (Table.20) and Fig24. 
PART – 4 
NITRIC OXIDE SCAVENGING METHOD 
From the table, it can been seen that the ethanolic extract of Cordia obliqua showed a 
percentage inhibition of 138.19 ± 1.18,while ascorbic acid showed  a percentage inhibition of 
199.67 ± 1.10 at a concentration of 333.33µg/ml.  The IC50 value calculated using the linear 
regression analysis was found to be 111.47and 83.47μg/ml for the ethanolic extract and 
ascorbic acid respectively.  
PART – 5 
REDUCING POWER ASSAY 
From the table, it can been seen that the ethanolic extract of Cordia obliqua leaves 
showed a percentage inhibition of 0.690 ± 0.002, while ascorbic acid showed a percentage 
inhibition of 1.097± 1.01.The graphical representations of the reducing power activity of the 
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ethanolic extract of Cordia obliqua and ascorbic acid were presented in Fig 26 showed a 
percentage inhibition of 1.097 ± 1.01 at a concentration of 500µg/ml (Table 22).   
SECTION – B 
Anti - inflammatory activity  
This study deals with the In-vivo pharmacological screening of the ethanolic extract 
of Cordia  obliqua leaves at a dose of 200 and 400mg/kg, for their anti- inflammatory activity 
by using carrageenan Induced rat paw edema method and the results were tabulated in Table 
23.  The results reveals that both the extracts at a dose of 200 and 400mg/kg, possesses 
significant Anti- inflammatory activity when compared to control group (p<0.01). 
SECTION – C 
Antibacterial activity 
  This study deals with the In-vitro pharmacological screening of ethanolic extract of 
Cordia obliqua leaves for the antibacterial activity by the disc diffusion technique. The results 
obtained indicate that the ethanolic extract of Cordia obliqua leaves had significant effect on 
all the microorganisms tested. EECO was tested for the antibacterial activity against 
Escherichia coli, Pseudomonas aurogenosa, Staphylococcus aureus and streptococcus 
pyogens. Zone of inhibition of EECO was found to be, for Escherichia coli  400µg -12mm, 
600µg-18mm, Pseudomonas aurogenosa -400 µg-10mm, 600µg -18mm , Staphylococcus 
aureus -400µg -12mm , 600µg -18mm, Streptococcus pyogenes 400µg -10mm , 600µg-
18mm) compared to imipenum. These results indicate that EECO has exerted signigicant 
antibacterial activity against all the four bacterial pathogens at 400µg and 600 µg/ml 
concentrations, which is comparable with 30µg imipenum (Table 24) and Fig. 27- 31.. 
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CHAPTER- VIII 
CONCLUSION 
  
This dissertation covers the pharmacognostical parameters of the leaves of cordia 
obliqua willd., belonging to the family Boraginaceae. The macroscopical , microscopical 
characters, powder analysis, quantitative microscopy and physical standards like ash values, 
extractive values, loss on drying, swelling index, foaming index, fluorescence analysis have 
been studied and presented. 
 The gist of the findings derived from the investigations under this project is furnished 
in the following concluding lines. 
 Pharmacognostical parameters have been determined for the leaf of Cordia obliqua in 
order to substantiate and identity the plant for future work. 
 The kinds of microstructure have been recognized as tools to measure the 
phylogenetic relationships under light microscope, to resolve taxonomic controversies and to 
establish the botanical identity of the plant.  
 Preliminary phytochemical screening of the leaf of Cordia obliqua reveals the 
presence of sterols, carbohydrates, aminoacids, proteins, alkaloids, saponin, flavonoids, 
tannins and mucilage. 
 Determination of phenolic content, flavonoid and tannin content confirms that 
significant concentrations of these phyto constituents are present in the ethanolic extract of 
leaves of cordia obliqua willd. 
 TLC studies were performed with the ethanolic extract of the leaf to identify the 
phytoconstituents present in the leaf of this plant. 
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 HPTLC finger print studies were performed to evaluate the active constituents present 
in the leaf of the plant. 
Pharmacological screening confirms that the ethanolic extract of Cordia obliqua 
leaves have showed significant antioxidant activity which was evaluated by 
 Free radical scavenging by DPPH assay     
 Ferric Reducing Power Assay 
 Nitric oxide scavenging assay 
 Phosphomolybdenum Assay 
 Reducing power Assay 
Ethanolic extract of Cordia obliqua leaves also showed significant anti- inflammatory 
activity which was evaluated by  
 Carrageenan induced paw edema method. 
 The ethanolic extract of Cordia obliqua leaves (EECO) exhibited antibacterial activity 
against Escherichia coli, pseudomonas aeruginosa, staphylococcus aureus and streptococcus 
pyogens. Anti- bacterial activity of this extract against these microorganisms was significant 
comparable with standard drug imipenum.  
 The above results reveal that, the ethanolic extract of Cordia oblique  leaves (EECO) 
had showed significant antioxidant anti- inflammatory activity and moderate antibacterial 
activity. These activities may be due to the presence of the phytoconstituents like flavonoids, 
tannins etc., present in the leaves of Cordia obliqua. 
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Future aim of this study is to isolate the pharmacologically potent phytochemicals 
responsible for the above activities and detailed investigation for its exact mechanism of 
action which can result in complimentary to those of existing anti-inflammatory, antibacterial  
and antioxidant agents to deduce a definite Conclusion. 
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